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During Lineages of Neural and Epidermal Formation 
Carcinoma of Human Embryonal Differentiation the 
Cells. 
Victoria Buyers Christie 
Within the ectoderm of the developing human embryo, cell fate determination is 
largely modulated by factors activated by cell-to-cell signalling. In vertebrates, 
ectoderm primarily differentiates into neural cells that make up the central nervous 
system and lining epithelium, commonly known as the skin epidermis. One of the 
main regulators of this process is the bone morphogenetic protein (BMP) signalling 
pathway. While this pathway, and its involvement in ectodermal patterning, has been 
well studied in lower vertebrates there is little data available for its role in human 
ectodermal development. The main aim of this investigation was to establish whether 
the human TERA2.SP12 embryonal carcinoma (EC) stem cell line may be a viable 
model useful in the study of this particular mechanism in humans. Pluripotent human 
embryonal carcinoma cells have already been shown to represent a researchable 
model of human embryogenesis. It has also been shown that the differentiation of the 
human EC cell lines can be induced in a controlled manner using certain reagents 
such as retinoic acid and hexamethylene bisacetamide (HMBA). In this study it has 
been determined that the TERA2 EC cell sub-line TERA2.SP12 can also be induced 
to differentiate in a controlled manner. Retinoic acid induces cultured TERA2.SP12 
cells to differentiate into a variety of cell types, including neurons and glial cells. 
Using molecular techniques such as flow cytometry, western analysis, 
immunocytochemistry and RT-PCR these cultures were seen to express a range of 
proteins associated with the neural lineage. Non-neural cell types are also found in 
these cultures that are morphologically similar to those found when TERA2.SP12 EC 
cells are exposed to HMBA. Differentiation of TERA2.SP12 EC cells induced by 
HMBA was shown to differ to that induced by retinoic acid in that no 
morphologically identifiable neurons are observed in cultures grown as adherent 
monolayers. Through analysis of specific proteins it was noted that the expression of 
neural markers was significantly reduced. Interestingly, cells exposed to HMBA were 
found to regulate significantly higher levels of certain extra-cellular proteins such as 
fibronectin, laminin and cytokeratin-8. One of the mechanisms that these molecules 
have been previously associated with is the development of epidermis. Proteins and 
genes present in the BMP signalling pathway have also found to be expressed by 
these TERA2.SP12 differentiating cultures. These results indicate that retinoic acid 
induces the formation of neural tissues as well as non-neural tissues from human EC 
cells. Exposure to HMBA, however does not result in terminally differentiated neural 
phenotypes but induces the formation of a different lineage expressing high levels of 
markers that could be associated with developing epithelia such as immature 
epidermis. Accordingly, I conclude that the TERA2.SP12 EC cell system may be 
utilised as a potential model for cell fate specification between neural and non-neural 
lineages in man. 
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Chapter 1 
Introduction 
1.1 Cell Fate Determination in the Embryonic Ectoderm: 
After a zygote is fertilized the cells within it start to divide and eventually begin to organize 
themselves into a structured mass containing three distinct layers of cells, termed the germ 
layers. This process is called gastrulation and begins on day 14, ending on day 19 of human 
embryonic development. These germ layers are called the endoderm, mesoderm and 
ectoderm they are derived from the epiblast and they give rise to tissues of the embryo 
(Figure 1.1). In brief, the ectoderm develops into the outer epithelia and nervous system, the 
endoderm forms the epithelial linings of the respiratory and digestive tracts; including the 
glandular cells of the liver and pancreas, and the mesoderm forms the smooth muscular 
coats, connective tissue, skeleton, striated muscle, reproductive and excretory organs, the 
vessels supplying these organs, and blood cells and the bone marrow. Cells within the germ 
layers have the ability to differentiate into terminal end products and migrate away from the 
layers, but are also able to self-renew and replenish dividing cell populations within the 
layers when required, and are therefore termed stem cells. 
Figure 1.1. Simple diagrammatical overview of the three germ layers and the specialized 
cells arising from their differentiation. 
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In the developing embryo cell fate determination is firstly modulated by various maternal 
factors. However, the final orientation of the body plan primarily occurs as a result of 
communications between cells or to a lesser extent by signal transmissions across the 
different germ layers. This is a critical process i f the correct body axis is to be established. 
One area in which this cell fate determination is particularly well researched is in the 
ectoderm. In the vertebrate ectoderm, ventral stem cells differentiate into epidermis and the 
dorsal ectoderm differentiates into the components that make up the central nervous system 
(CNS). Spemann and Mangold first carried out studies on the amphibian, Xenopus Laevis, 
which led to their proposal that neural induction occurred in the ectoderm in 1924. In one 
study Spemann and Mangold grafted a region of the blastopore containing the dorsal lip 
onto the ventral side of a gastrula newt. This grafted area developed an entire second body 
axis (Figure 1.2a). Within this new body axis a secondary nervous system was established 
using cells from the host's ectoderm, which would normally have formed the epidermis 
(Figure 1.2b). Spemann and Mangold concluded that neural induction could be induced in 
the embryonic ectoderm and that the signals required for this induction were found in the 
dorsal lip (latterly termed the Spemann organizer). 
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Figure 1.2: 
Diagrammatic overview of Spemann and Mangold's conclusions from their studies of 
ectodermal patterning in Xenopus laevis. a) A graft was taken from the blastopore of a 
early gastrula frog, containing the dorsal lip, and transplanted onto the ventral side of a 
gastrula newt, resulting in the formation of an additional body axis (left panels). This does 
not occur in grafts of late gastrula material (right panels), b) Normal ectodermal 
development is shown in the left hand panels where dorsal ectoderm forms epidermis and 
ventral ectoderm forms neural tissue. If ectoderm from the dorsal area is transplanted into 
the ventral area during early gastrulation, the transplanted tissue forms neural cells. This 
shows that neural tissue is induced during gastrulation. (Diagrams modified from Principles 
of development; Wolpert L et al 1998) 
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1.1.2 Discovery of the Default Neural Pathway: 
After Spemann and Mangold's original studies in 1924, further experiments identified 
several neural inducers that are expressed and secreted from the Spemann organizer. The 
most notable of these inducers are noggin, follistatin and chordin, all of which are able to 
induce neural tissue formation directly. The neural inducing properties of noggin were first 
discovered by Lamb et al. in 1993, they showed that noggin could induce anterior brain 
markers but not hindbrain or spinal cord markers which was the expected expression profile 
of an endogenous neural inducer as this is the area where neural formation takes place. 
Similarly follistatin was shown to be expressed in gastrula in the Spemann organizer and 
was able to induce neural tissue types in animal caps with the absence of any mesoderm 
(Hemmati-Brivanlou et al 1994). In further experiments Sasai et al 1994 demonstrated the 
neural inducing properties of chordin where they went on to show that both the injection of 
chordin mRNA and chordin as a soluble protein resulted in the direct formation of neural 
tissues. 
Since the initial discovery of neural induction by Spemann and Mangold (1924) it was 
universally considered that stem cells in the ectoderm would differentiate in an epidermal 
direction unless instructed otherwise, i.e. epidermal differentiation was the default pathway. 
However Grunz and Tacke (1989) were one of three groups to challenge this view. They 
discovered that i f cells in the early gastrula ectoderm of the Xenopus laevis were 
disaggregated and not exposed to any inducing factors, and kept in this state for up to 5 
hours before being reaggregated, the cells would differentiate in a predominantly neural 
direction. This study suggested neural formation was the default pathway, and that in normal 
circumstances the ectoderm formed epidermis as a result of inhibitory factors suppressing 
this default neural differentiation pathway. This theory was supported by the work of 
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Hemmati-Brivanlou and Melton (1994), when they injected a truncated activin type I I 
receptor into Xenopus animal caps, resulting in the production of neural tissues. This 
mutated ligand has been shown to block the activity of activin and other ligands associated 
with the transforming growth factor-p (TGF-P) super-family in a dominant inhibitory 
fashion. Hemmati-Brivanlou and Melton (1994) concluded that the mutated receptor bound 
to the normal ligand and rendered the complex inactive, suggesting that the formation of 
neural tissue could only occur i f the organizer secretes factors that inhibit TGF-p signalling, 
otherwise epidermis is formed. 
1.1.3 The Bone Morphogenetic Protein Signalling Pathway; 
As the default pathway was now considered to be neural, scientists began the search to 
identify an inhibitor of this pathway, which presumably must be present throughout most of 
the ectoderm where formation of epidermis takes place. Wilson and Hemmati-Brivanlou 
first reported finding such an inhibitor in 1995. They hypothesized that the neuralisation of 
the animal caps in previous experiments was a result of diluting away the tonic epidermal 
inducer, therefore i f the inducer was re-introduced, epidermal differentiation would result. In 
the light of the earlier work with the mutated activin receptor (Hemmati-Brivanlou and 
Melton 1994), Wilson and Hemmati-Brivanlou concluded that members of the TGF-P super-
family were possibly good candidates for epidermal inducers. In cell dissociation assays, the 
ectoderm was dissociated and soluble factors, which were related to the TGF-p super-
family, were added to the cultures in an attempt to induce the epidermal lineage. Activin was 
found to inhibit neuralisation, however, it did not induce epidermal differentiation, but 
induced mesoderm. Eventually it was discovered that bone morphogenetic proteins (BMPs), 
which are related to the TGF-P super-family, especially BMP4 and to a lesser extent BMP2 
and 7, were strong epidermal inducers (Wilson and Hemmati-Brivanlou 1995, Suzuki et al 
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1997). In both reports, BMPs were found to be present in the embryonic ectoderm, 
appearing to inhibit neuralisation and also promoting the formation of epidermal derivatives. 
In support of these initial studies were experiments that blocked BMP activity in intact 
ectoderm resulting in the formation of neural tissues, suggesting that in normal 
circumstances, BMP signals inhibit neural induction (Hawley et al 1995). Figure 1.3 
provides an overview of the findings of these investigations. 
The discovery that BMPs were involved in the inhibition of neural cell fates and were 
considered to be inducers of epidermal lineages, led to the notion that neural inducers 
secreted in vivo by the Spemann organizer are likely to work by blocking BMP signalling. 
Studies in Xenopus on noggin and chordin, established that they were both able to bind 
directly with BMPs with a higher affinity than that of the normal ligand receptor complex 
(Zimmerman et al 1996, Piccolo et al 1996). This interaction prevents BMPs from binding 
to their receptors, inhibiting any signal transduction along the BMP signalling pathway that 
would result in the inhibition of the default neural pathway. At present it is uncertain 
whether follistatin disrupts the BMP signalling in a similar way, but it is known follistatin 
does interact with numerous BMPs, including BMP-4 (Fainsod et al 1997). Follistatin 
appears to form an inactive trimer between itself, the BMP, and the BMP receptor thereby 
blocking any signal transduction (Iemura 1998). 
Down stream components of the BMP signalling pathway have also been shown to induce 
epidermal derivatives in dissociation assays (Massague 1997). Initially, BMPs bind 
cooperatively to type I and type I I TGF-P receptors. Subsequent to activation of the BMP 
receptor, intracellular Smad proteins transmit the signal downstream (Massague 1997). 
Smad proteins constitute a large family of proteins that are able to transduce signals for 
different TGF-p ligands. Smadl and Smad5 and possibly Smad9 appear to play a positive 
role in the activation and transmission of the signals along the BMP pathway. They have 
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been shown that when they are overexpressed they are able to induce epidermal derivatives 
in dissociation assays as well as inhibiting neural formation (Wilson et al 1997). Smad4 
alone does not appear to be able to transduce signals for any TGF-P ligand, but it does seem 
to be a common partner essential for the signal-transducing Smads (Zhang et al 1997). 
While Smad proteins 1, 5 and 9 appear to work in concert with the BMPs, and promote the 
formation of epidermal tissues, another group of Smad proteins (Smad6, 7, and 8) have been 
cloned which have been shown to inhibit the activity of the TGF-P ligands (Massague 
1998). Smad6 seems to block the signalling pathway by binding to Smadl and rendering it 
inactive, Smad7 disrupts the signalling by inhibiting all TGF-P ligands, including those used 
by the BMP signalling pathway (Hata et al 1998). Smad8 also blocks TGF-P ligands, but 
only those ones specific to the BMP signalling pathway. In all cases overexpression of these 
Smads is able to induce neural differentiation in experiments using Xenopus animal caps 
(Hayashi et al 1997). It appears that these anti-Smad proteins may be important in the 
regulation of the amount of BMP signalling in any one cell at any one time. 
Active Smadl/Smad4 complexes are able to translocate into the nucleus of the cell and from 
there they activate the expression of various genes that encode for a number of transcription 
factors including msxl, gata-1 and vent. These factors are able to inhibit neural 
differentiation and induce the expression of particular genes which result in the formation of 
the epidermis. The activity of molecules associated with the BMP signalling pathway is 
summarized in Figure 1.4. 
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Figure 1.3: Cell fate determination in the ectoderm of the Xenopus laevis embryo. When 
the ectodermal explant (animal cap) of the blastopore was cultured in buffered saline it 
formed epidermis. However if the Spemann organizer was present in the culture the cell fate 
switched to neural tissue, thereby backing up claims that the organizer secretes neural-
inducing factors, later identified as noggin, follistatin and chordin, which are responsible 
for CNS development in vertebrates. If the animal cap is dissociated and maintained in this 
state in Ca2+ and Mg2+free buffer for up to 5 hours, the resulting cellular differentiation is 
in a neural direction. This indicates that with the presence of no outside inducing agents the 
animal cap will take on a neural call fate. In other words neural cell fate is the default 
pathway in the embryonic ectoderm. When dissociated cells were incubated with bone 
morphogenetic proteins (BMPs), epidermis was the resulting product after the cells had 
been reassociated, implying that BMPs inhibit default neural induction. This observation 
seemed to indicate that in the ectoderm, BMP signalling may be responsible for inhibiting 
neural differentiation and inducing epidermal development. 
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Figure 1.4: Overview of the BMP signalling pathway. BMPs bind to type I and IITGF-J3 receptors 
on the cell surface membrane which activate intracellular Smadproteins. ActivatedSmadl forms a 
complex with Smad4 which is then translocated into the nucleus. The complex activates specific 
transcription factors such as msxl, gata-I and vent that in turn initiate the expression of epidermal 
genes leading to the formation of epidermis. This complex also represses the expression of neural 
genes, inhibiting neural formation. The pathway can be blocked at several stages. Neural inducers 
secreted from the Spemann organizer, such as noggin and chordin bind directly with BMPs 
stopping them from binding with their receptors. Within the cell, Smadl and 8 prevent activation 
of Smadl, and Smad6 stops the formation of the Smadl/4 complex by binding to Smadl rendering 
it inactive. All methods serve to modulate the amount of BMP signalling received by any one cell. 
(Smad proteins in the oval shapes aid the transmission of BMP signals, whilst Smads in the 
rectangles antagonize this signalling pathway). 
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1.1.4 Conservation of the Default Neural Pathway; 
Most of the studies reviewed so far were carried out in Xenopus laevis, however the 
conservation of the basic mechanism findings involved in cell fate determination in the 
ectoderm appears to be high across many species. For instance, studies in Drosophilia 
revealed that although neural lineages arise from the ventral ectoderm, BMP activity must 
still be inhibited for this process to take place (Ferguson and Anderson 1992). Homologs of 
BMP2/4 have been identified in Drosophilia, along with homologs for chordin and are 
termed decapentaplegic (dpp) and short gastrulation (sog) respectively. Inhibition of dpp 
results in the formation of neural cell types which would, under normal conditions, have 
formed the epidermis (Ferguson and Anderson 1992). It has also been shown that sog and 
Xenopus noggin antagonize dpp activity before it binds to the dpp receptor. This reinforces 
the hypothesis of the default neural pathway, and showing that it is conserved between 
species as diverse as Drosophilia and Xenopus (Holley et al 1996). At present there is a lack 
of data about inhibition of the BMP pathway and its relevance in neuralisation in higher 
vertebrates. However, chick, fish and mammal equivalents to the Spemann organizer have 
been identified that induce a secondary body axis when transplanted into separate 
blastocysts (Waddington and Schmidt 1933, Oppenheimer 1936). Furthermore, homologs to 
the neural inducers noggin, follistatin and chordin have also been found to be expressed by 
the ectoderm in higher vertebrates (Waddington and Schmidt 1933, Oppenheimer 1936), 
including humans (Beddington 1994). 
Mutations in the zebrafish have uncovered similar findings to those seen in Xenopus studies. 
A null mutation exhibited in the BMP2 gene appears to result in enlarged neural plate 
formation (Kishimoto et al 1997), whereas a null mutation in chordino, a homolog of 
chordin, results in a dramatic reduction in size of the neuroectoderm (Schulte-Merker et al 
1997). These data further support the theory that BMPs inhibit the formation of neuronal 
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tissues as well as inducing epidermal production and are therefore essential for the normal 
ectodermal development. Furthermore, these studies add more weight behind the argument 
that the neural default pathway exists and also show that this mechanism appears to be 
highly conserved between Xenopus and many other different species. 
Experiments carried out in murine cell lines tried to establish whether the default neural 
pathway model was also conserved during mammalian embryonic development. At the time 
the model culture system of choice was the PI9 pluripotent mouse embryonal carcinoma 
(EC) stem cell line. PI9 EC cells can be induced to form neurons with the introduction of 
retinoic acid into the culture medium (Hoodless and Hemmati-Brivanlou 1997). When 
BMP4 was also introduced to cultures, retinoic acid induced neuronal development was 
inhibited and an increased expression of markers for epidermis was recorded (Hoodless and 
Hemmati-Brivanlou 1997). These data further indicate that neuronal development may occur 
due to the antagonism of the BMP signalling pathway. Supporting this argument was 
evidence that showed that transfection of the truncated activin receptor (similar to that used 
in the Xenopus studies) or of follistatin into undifferentiated P19 EC stem cells resulted in 
neural differentiation (Hoodless and Hemmati-Brivanlou 1997, Fainsod et al 1997). At 
present research has being carried out to try and establish successful knock-out mouse 
models which target deletions in the BMP signalling pathway. When a successful model has 
been created the hope is that it will be able to determine the extent of the role which BMPs 
play in the inhibition of neuronal development within the ectoderm in mammals. So far 
models have been created which have eliminations of either BMP2, BMP7, the BMP 
receptor or Smad4 (Zhang and Bradley 1996, Dudley et al 1995, Mishina et al 1995, Sirard 
et al 1998). However, none so far have been very informative due to either being lethal or 
having little effect on ectodermal development (reviewed in Weinstein and Hemmati-
Brivanlou 1999). 
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Whilst there is compelling evidence suggesting that the mechanisms that function to 
determine cell fate in the ectoderm are conserved in vertebrates, there are significantly less 
data describing their activity in humans. Obviously, ethical and moral issues surrounding the 
use of human embryonic and foetal tissues limit the extent of research into this area. 
Moreover, there is a lack of suitable and readily available model systems to explore this 
mechanism in vitro. During this investigation, I describe the development of an in vitro cell-
based system that has the potential to enable researchers to study the formation of neural and 
epidermal lineages in man. This study shows that a cell line created from embryonal 
carcinoma cells have the ability to differentiate into either a neuronal or epidermal lineage in 
response to certain factors. 
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1.2 Embryonal Carcinoma Stem Cells: A Model of Mammalian 
Embrvogenesis 
Embryonal carcinoma (EC) cells have long been understood to be the pluripotent stem cells 
whose differentiation can lead to the many differentiated cell types found in germ cell 
tumours (GCT). EC cells are most commonly found in tumours termed teratocacinomas, and 
they are understood to be the malignant counterpart of embryonic stem (ES) cells (Andrews 
et al, 2001). EC stem cells found in teratocarcinomas have been of great interest to 
pathologists for some time and have been shown to represent a researchable model of 
embryogenesis (Andrews et al 1987). The discovery that EC and ES cells have similar 
properties has helped overcome the many ethical and moral issues surrounding the study of 
human embryogenesis, which was greatly hampered due to the many ethical and moral 
issues surrounding the use of human embryonic material. EC cells are also a valuable 
medical tool that can be used to research a medically significant tumour type, namely 
testicular cancer. 
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1.2.1 Germ Cell Tumours 
Teratocarcinomas are histologically complex tumours that belong to a class of neoplasms 
termed germ cell tumours (GCTs) (See Table 1.1). The most common form of this tumour 
type is the dermoid cyst of the ovaries. Such cysts develop from a totipotent germ cell, the 
primary oocyte, after it has been parthogenetically activated. In other words, the oocyte 
becomes self-activated and starts to develop as a fertilized zygote. During this process the 
oocyte starts to differentiate but after a while the cells become disorganized, forming a 
jumble of embryonic and foetal tissue types leading to the formation of a teratoma. Since 
teratomas arise from totipotent stem cells, they can give rise to many cell types necessary to 
form mature tissues in the body. Such differentiated tissues include clumps of hair, teeth, 
bone and sebaceous material (Figure 1.5). Dermoid cysts can grow very large in size, 
generally reaching about 10cm in diameter i f not detected, but generally remain benign. In 
contrast, testicular GCTs, which come about due to transformations of the primitive germ 
cells prior to meiosis, are usually highly malignant. 
Generally speaking testicular tumours can be split into two sub-groups, seminomas and non-
seminomas GCT. A seminoma is described as a homogeneous GCT tumour containing 
uniform cells that resemble primordial germ cells. Non-seminoma GCT are described as 
heterogeneous tumours, they may contain one or more of the cell types that resemble 
extraembryonic tissues of the trophoblast or yolk sac, (i.e. choriocarcinoma or yolk sac 
carcinoma cells, respectively). 
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Table 1.1: Simplified description of the various components and features of Germ Cell 
Tumours. (Derivatised from Andrews et al. 2001) 
Histological Type Description Comments 
Teratoma A tumour that contains an array 
of differentiated somatic cell 
types 
The tumour may contain 
organised well-recognizable 
anatomical structures such as 
teeth. These tumours are often 
benign, but the malignant 
potential is well known. The 
most common form is the 
benign dermoid cyst of the 
ovary 
Embryonal 
carcinoma 
'Undifferentiated' epithelial 
cells resembling embryonic 
cells of the ICM and the 
primitive ectoderm. 
Highly malignant tumours, the 
cells are generally regarded as 
stem cells able to differentiate 
into a range of histological cell 
types. 
Teratocarcinoma A tumour that contains both 
teratoma and embryonal 
carcinoma. 
The malignancy of these 
tumours is due to their 
embryonal carcinoma 
component. 
Yolk sac 
carcinoma 
Cells resemble those of the 
extraembryonic 'yolk sac' 
In mouse tumours cells may 
resemble parietal or visceral 
yolk sac, in humans no such 
clear distinction is evident. 
Choriocarcinoma Cells resemble cyto- and 
syncytiotrophoblast of the 
placenta. 
These do not occur in GCTs of 
the laboratory mouse. 
Seminoma Relatively uniform cells 
resembling 'primordial germ 
cells' 
A malignant tumour that does 
not occur in the laboratory 
mouse. Known as 
Dysgerminoma in females. 
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Figure 1.5: Structural features of a teratoma: A: Low power microscopic appearance of 
teratoma. The three embryologic germ layers are represented by skin (ectoderm), cartilage 
(mesoderm), and a colonic gland (endoderm) 
rww.medlib.med.utah.edu/WebPatr^EDHTML/PED050.htmU. 
B: Gross appearance of a benign ovarian dermoid cyst. 
www.kumc.edu/instruction/medicine/pathology/ed/ch 18/c 18 dermoid gross.html. 
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GCT can also contain other tissue types such as nerve, bone or muscle similar to their 
teratoma counterparts. Most testicular GCTs also contain undifferentiated epithelial cells 
which resemble the embryonic cells of the inner cell mass (ICM) and primitive ectoderm. 
These undifferentiated epithelial cells have been deduced by studies reporting on their 
biochemical and immunological properties, as well as in their developmental potential 
(Andrews et al 1983). The undifferentiated epithelial cells are the EC cells, and it is these 
cells which give the tumours there malignant characteristic. Kleinsmith and Pierce (1964) 
conducted experiments proving the malignancy of such EC cells. They transplanted a single 
murine EC cell into a suitable mouse host and discovered that a whole new teratoma or 
teratocarcinoma formed. These studies also showed the ability of EC cells to differentiate 
into the wide range of tissue types found in the tumour. In most cases the differentiated 
products of the EC cells have a limited proliferative ability and have lost their malignant 
properties. 
The term teratocarcinoma is generally given to GCT that contains both embryonic tissues 
(teratoma) and EC cells. Teratocarcinomas of the testis are the main tumour type used by 
developmental biologists for research purposes due to their apparent similarity to 
embryogenesis and the fact they arise from germ cells. Figure 1.6 summarizes the close 
relationship of GCTs to their normal germ cell and embryonic counterparts. 
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Figure 1.6: Diagram depicting the similarities between normal germ cell and their 
malignant counterparts, germ cell tumours. In normal embryogenesis the primordial germ 
cells follow a specific pathway creating embryonic stem cells which then differentiate into 
the extraembryonic and somatic cells. The tumour production follows a similar pathway 
resulting ultimately with corresponding differentiated cells. (Modified from Andrews et al, 
2001) 
Primordial Germ Cells \ 
Germ Cells 
Carcinoma-in-situ (CIS) 
Gametes 
Embryonal Carcinoma Embryonic Stem Cells 
Extraembryonic 
Stem Cells (Yolk 
Sac Carcinoma, 
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\ / Extraembryonic 
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/ \ 
Somatic Cells 
(Teratoma) 
Somatic cells 
(embryo) 
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1.2.2 Historical Studies of Embryonal Carcinoma Cells 
The importance of EC cells becomes apparent when discoveries made by Solter and 
Damjanov (1979), and Andrews (1983), using EC cells, led to ground-breaking research in 
isolating murine embryonic stem (ES) cells (Evans and Kaufman, 1981; Martin, 1981), then 
ultimately to the isolation of human ES cells (Thomson, 1998). 
It is suggested that the formation of teratocarcinomas reflects the processes of embryonic 
development. It was therefore thought that EC cells might resemble undifferentiated stem 
cells that are found in the early embryo. However the study of this concept was hampered 
due to the rarity of such tumours occurring. This problem was in part overcome with the 
discovery that provided a model system by Stevens and Little (1954). They reported that 1% 
of male mice of strain 129 develop testicular teratomas. Stevens (1964) also discovered that 
the incidence of the tumours occurring could be increased by transplanting the genital ridges 
of early embryos to the testis capsule of adult mice. There is a only a short time period in 
development when the embryonic genital ridges are susceptible to such transplantation, and 
in the mouse this is from 12 to 12.5 day old embryos. Solter and Damjanov (1979) also 
reported that these testicular GCTs could be induced in other strains of mice from 
ectopically transplanted embryos. 
The testicular GCTs forming either spontaneously in 129 mice or following transplantation 
methods can be split into two groups. One group contains the tumours that can be 
maintained as undifferentiated EC cells in-vitro, but are still able to form teratocarcinomas 
when transplanted back into syngeneic mice hosts. These cells are said to be pluripotent. 
The other group contains the tumours which are non-retransplantable. These are known as 
teratoma tumours and do not contain any EC cells (Andrews et al 2001). 
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Stevens (1967) studied mice homozygous for mutations at the steel (SI) locus to prove that 
teratocarcinomas were derived from germ cells. Steel encodes for stem cell factor, which is a 
growth factor essential for the survival of the primordial germ cells when they migrate 
through the genital ridge of the developing embryo. Mice homozygous for the SI gene have 
no stem cell factor and are therefore infertile due to the fact that the primordial germ cells do 
not survive during migration. In this study, Steven's crossed the SI locus on to the 129 
mouse background. The SI experiments concluded that all of the genital ridges of Sl/Sl mice 
on a 129 background did not produce any teratomas when, as investigated and proved before 
by Stevens and Little (1954), 1% should have produced tumours (Figure 1.7). This data 
therefore supported the hypothesis that the origin of the teratoma and teratocarcinoma is 
likely to be the primordial germ cell (Stevens, 1967). 
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Figure 1.7: 
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1% develop spontaneous tumours. 
Evidence produced by Stevens (1967) concluded that the primordial germ cell is the 
origin of teratomas and teratocarcinomas: Mice homozygous for the steel (SI) gene 
(Sl/Sl) are found not to produce teratomas of the testis, where, as it has been proved before, 
1% should develop spontaneous tumours. This 1% tumour development is seen with mice 
heterozygous for the SI (Sl/n) gene or who have a normal (n/n) genotype. The SI gene 
encodes for stem cell factor, which is essential for primordial germ cell survival as they 
migrate through the genital ridge of the developing embryo. Mice homozygous for the SI 
gene produce no stem cell factor thus no primordial germ cells would survive the migration, 
and given the complete absence of a GCT, it can be concluded that the origin of a teratoma 
or teratocarcinoma is most likely to be the primordial germ cell. 
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1.2.3 Embryonal Carcinoma in the Laboratory Mouse 
• Murine Embryonal Carcinoma Cell Lines 
The increasing importance of EC cells in both the study of cancer research and 
embryogenesis lead to the derivation of several cell lines for research purposes. In essence, 
EC cells were isolated from murine teratocarcinomas then seeded onto plates and cultured. 
This type of work was originally pioneered by Kahn and Ephrussi (1970). Since then many 
others, such as Pfeiffer et al (1981) and Jones-Villeneuve et al (1982), have also established 
murine EC cell lines. A typical feature of many of the established lines is that they can be 
maintained as undifferentiated EC cells in-vitro, but when they are transplanted back into a 
suitable mouse host they form the many differentiated tissue types that are associated with 
teratomas. Cultured EC cells are therefore still capable of differentiation into multiple tissue 
types. On this basis, such cell lines are said to contain 'pluripotent' EC cells. However, some 
EC cell lines seem to lose the ability to differentiate and are therefore termed 'nullipotent'. 
This is understood to be due to mutations within the EC cells themselves. Furthermore, such 
genetic mutations are likely to give EC cells their malignant properties, but it may also 
interfere with the cells ability to differentiate, i.e. they are selectively at an advantage i f they 
can mass replicate themselves to produce more tumour cells. 
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• Differentiation of Murine Embryonal Carcinoma Cells 
Subsequent to the establishment of murine EC cell lines, scientists actively investigated their 
propensity for differentiation. Investigation into the mechanisms of cell differentiation 
would have many useful implications for developmental and cancer biologists, alike. 
Some pluripotent EC cell lines could spontaneously differentiate in culture. For example, i f 
the murine cell line PCC3 was allowed to reach confluence in culture and was maintained in 
that state for several days then the cells started to differentiate into a variety of cell types 
including nerve and muscle (Andrews et al, 2001). Indeed, many of the early studies of EC 
cell differentiation were carried out with spontaneously differentiating cell lines, mostly by 
the differentiation of embryoid bodies that were produced when the cells were cultured in 
suspension (Martin and Evans 1975). However, the study of this uncontrolled differentiation 
made it difficult to analyse the underlying biochemical processes and mechanisms involved. 
Therefore, a breakthrough for this problem came with the discovery that the apparently 
nullipotent cell line F9 could be induced to differentiate when the cultures were exposed to 
retinoic acid (RA). After exposure to RA the cells differentiated into cells that resembled 
parietal endoderm (Strickland et al 1980). This discovery highlighted the importance of 
retinoic acid for the processes of regulating embryonic development. Other cell lines were 
also induced to differentiate when exposed to retinoic acid, these lines included PCC7 
(Figure 1.8) (Pfeiffer et al 1981), and also P19, one of the most studied line in this area 
(Jones-Villeneuve et al 1982). The PI9 cell line was found to differentiate into neural cell 
types when exposed to retinoic acid and muscle cell types when exposed to 
dimethylsuloxide (DMSO). It could also be induced to differentiate into other cell types 
when exposed to alternative substances such as hexamethylene bisacetamide (HMBA) 
(Andrews et al, 1990). 
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Figure 1.8:: Mouse PCC7 embryonal carcinoma stem cells and their differentiated derivatives: 
A: Undifferentiated PCC7pluripotent embryonal carcinoma cells B: Embryoid bodies formed by culture 
in suspension. C: Differentiation into neurons and other cell types after induction with retinoic acid. 
Bars A: 20\x.m B:100\xm C:15\xm ( Courtesy of Dr S Przyborski.) 
• Relationship of Murine Embryonal Carcinoma Cells to the Early 
Embryo 
With the establishment of murine EC cell lines during the sixties and early seventies the 
hypothesis that EC cells resemble the stem cells found in the early embryo was tested. At the 
time, one of the many methods used involved the relatively new technique of producing 
antisera to specific cell surface antigens. Boyse and Old (1969), claimed that the specific 
cell-surface antigens could play a vital role in the regulation of cell behaviour and 
differentiation. These ideas were quickly put into practice to identify specific embryonic 
cell-surface antigens with the intention to test whether EC cells expressed the same cell-
surface antigens as their supposed embryonic stem cell counterparts, therefore providing 
further evidence in support of this hypothesis. 
Artzt et al (1973) was one of the first groups to put the use of antisera into practise using EC 
cells. The method they used involved immunising adult 129 mice with EC cells of the F9 
line that were also of 129 origin. As the implanted EC cells were 'foreign' the host elicited 
an immune response producing antibodies specific to the embryonic EC cells that could be 
collected and studied. When tested by cytotoxicity and immunofluorescence assays, the anti-
F9 sera produced from immunized 129 mice was found to express antigens found on EC 
cells but that were not expressed on a range of other differentiated cells. The same antigens 
were also discovered to be expressed by cells of the inner cell mass (ICM) of the embryonic 
blastocyst, thus producing significant evidence that EC cells are the malignant counterpart of 
embryonic cells. 
Subsequent studies backed up these initial findings with experiments using monoclonal 
antibodies. The initial findings using the anti-F9 sera were clouded with controversy at the 
time. This was due to the fact that anti-F9 sera was a polyclonal antisera and some groups 
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were questioning whether it was related to key cell-surface molecules encoded by the T-
locus (Kemler et al 1976). One of the many difficulties of working with polyclonal antisera 
meant that the precise nature of this anti-F9 activity was never resolved, but a link to the T-
locus became more and more unlikely as research advanced. However, the findings using 
the F9-antisera were strong enough to inspire further study in the area, and using anti-F9 
sera as a starting point many reagents using monoclonal antibodies were produced that 
identified antigens with similar characteristics to the F9 antigen. The most interesting of 
these was the stage-specific embryonic antigen-1 (SSEA-1). This antigen was highly 
expressed both by murine EC cells and embryonic ICM cells. Moreover, it was likely that 
the polyclonal anti-F9 sera contained antibodies that recognised this epitope. 
More direct evidence linking EC cells and embryonic stem cells came about when a small 
number of EC cells were transplanted into blastocysts and the grafted EC cells contributed 
to the formation of mature tissues found in the chimeric off-spring (Brinster 1974). In this 
study, a small number of EC cells were taken from an agouti mouse, these were then 
transferred into a blastocyst taken from an albino strain of mouse by micro-manipulation. 
The blastocyst was then implanted into a pseudopregnant female and some of the subsequent 
off-spring had patches of agouti fur indicating that the EC cells had become integrated with 
the stem cells in the embryo and contributed to the formation of the developing embryo, 
(Figure 1.9). Papaioannou et al (1975) extended findings and used single cell clones to 
prove that pluripotent EC cells can also participate in normal embryogenesis. Papaioannou's 
group injected the EC cells into the blastocoel cavity of a developing embryo, and were able 
to show that the pluripotent EC cells injected had differentiated into many of the tissue types 
within the chimeric mouse that developed. Mintz and Illmensee, (1975) provided additional 
evidence that suggested the EC component within a chimeric mouse was capable of 
extending to the germ line, bringing the relationship of EC cells to ES cells closer still. 
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Many of these studies involving murine EC cells have greatly increased the basic knowledge 
of the molecules and mechanisms that are involved with embryonic development and 
differentiation. Accordingly, EC cells have proven to be a robust and simple tool for the 
study of developmental biology. 
29 
Figure 1.9: 
Experiments carried out by Brinster (1974) further backed up evidence linking EC cells to 
embryonic stem cells: A small number of EC cells were taken from an agouti strain of 
mouse and were transferred into a blastocyst taken from an albino strain of mouse. The 
blastocyst was then implanted into a pseudopregtiant female. The EC cells integrated with 
the stem cells in the developing blastocyst, resulting in some of the subsequent off-spring 
having patches of agouti fur. This experiment provided more direct evidence linking EC 
cells to embryonic stem cells. 
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1.2.3 Embryonal Carcinoma in the Human 
• Human Embryonal Carcinoma Cells 
It was known that while there is strong conservation between mammalian embryogenesis 
including mice and humans, there still remain significant differences between different 
species. Accurate models of human embryogenesis wi l l allow exploration of these 
differences in embryonic development of humans from other laboratory mammals. 
Human EC cells provide a useful model system for this type of research, as while they 
resemble embryogenesis, they overcome many of the moral and ethical issues surrounding 
the use of embryonic tissues and ES cells. They are also an invaluable tool used in the study 
of a medically significant form of cancer. 
One of the first human EC cell populations was isolated from a lung metastis originating 
from a testicular germ cell tumour (reviewed in Martin, 1980). The EC cells from this 
tumour were maintained as xenografts in mice, (Pierce et al 1957). Later, tumour tissues 
were explanted and grown in culture and EC cells were subsequently isolated and cultured 
directly in-vitro. One of the most well-known human EC lines created was given the name 
TERA2 (Fogh and Trempe, 1975). 
Initially, studies reported the conserved properties between mouse and human EC cells. 
These early results showed that some of the human EC cell lines also expressed the F9 
antigen. However, importantly, later comparative studies turned up interesting differences 
between the two cell types. It was detected that human EC cells did not express the SSEA-1 
antigen, the hallmark of murine EC cells (Andrews et al 1982). Instead they were shown to 
express two new antigens, namely SSEA-3 (stage-specific embryonic antigen-3) and SSEA-
4 (stage-specific embryonic antigen-4). These antigens had been previously been shown to 
only be expressed by cleavage-stage murine embryos, not by murine ICM cells or murine 
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EC cells. Other antigens have also been found to be expressed by the human EC cell surface, 
such as TRA-1-60, TRA-1-81 and GCTM2. TRA-1-60 has recently become a useful clinical 
serum marker in germ cell tumour patients, due to the fact that it is expressed by human EC 
cells, (Mason et al 1991). 
• Differentiation of Human Embryonal Carcinoma Cells 
One prominent feature in the early studies of the many human GCT-derived EC cell lines 
was their distinct lack of ability of many of the lines to differentiate into any well-
recognizable cell types (Andews and Damjanov 1994). This could have been due to the fact 
that their ability to differentiate would limit the tumour growth so therefore putting those 
cells at a selective disadvantage to more malignant mutant types. This apparent inability of 
the human EC cells to differentiate made it difficult to define them as EC cells, due to the 
ability to differentiate being a key diagnostic feature of an EC phenotype. However this was 
soon overcome with the establishment of human EC cell lines that did undergo limited 
differentiation and that showed distinct morphological changes as well as changes in 
expression of various markers when the cells were exposed to different culture conditions. 
The early studies of human EC cell differentiation involved examination in closest detail of 
the 2102Ep human EC cell line (Andrews et al 1982). 2102Ep EC cells spontaneously 
differentiate when they were cultured at low densities, yielding a morphologically and 
antigenically distinct cell type. The differentiation of 2102Ep human EC cells at low cell 
densities results in the down-regulation of the surface antigen SSEA-3, and the appearance 
of SSEA-1. Differentiated 2102Ep cells have been found to resemble trophoblastic giant 
cells. Differentiation induced in cultures seeded at low densities could indicate that cellxell 
contact is an important factor for maintaining the undifferentiated, malignant state. This is 
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backed up by the fact that the cell lines that show this low-density differentiation in-vitro do 
not appear to differentiate when grown as xenograft tumours (Andrews 1998). 
The apparent trophoblastic differentiation of the 2102Ep cell line along with other human 
EC cells lines indicates a notable difference between murine and human GCT. This 
difference being the frequent occurrence of trophoblastic elements in human but not in 
mouse teratocarcinomas (Damjanov and Solter 1974). This finding fits with the theory that 
murine EC cells are the malignant counterpart to the late ICM, or primitive ectoderm cells 
which have lost the capacity for trophoblastic differentiation, explaining why it is rare to 
find trophoblastic elements in murine teratocarcinomas. Human EC cells are thought to 
correspond to an earlier stage of embryonic development than mouse EC cells, for example, 
to cleavage-stage embryos, therefore retaining the capacity for trophoblastic differentiation. 
Along with the study of spontaneous differentiation in human EC cell lines many groups 
have investigated the ability of certain cell lines to differentiate under controlled culture 
conditions. For example, the initiation of differentiation by exposure to retinoic acid. The 
majority of pluripotent human EC cell lines share many of the typical features associated 
with EC cells in general (Andrews 1998), therefore strengthening the argument that, as in 
the mouse, human teratocarcinomas contain pluripotent stem cells that resemble those from 
the early embryo. The most extensively studied cell line in this area is the human pluripotent 
EC cell line known as TERA2. 
• TERA2 Human Pluripotent Embryonal Carcinoma Stem Cells 
The TERA2 EC cell line is one of the oldest and most extensively studied human GCT 
lines. It was derived in 1975 by Fogh and Trempe. Initially the TERA2 cell line was thought 
to be nullipotent. It took a few years to discover the pluripotent nature of the TERA2 cell 
line. This was due to the fact that TERA2 cultures are impure and frequently contain only a 
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few EC cells. Obviously this impurity and lack of EC cells made it difficult to carry out any 
analysis on the EC cell component. A more robust, pure line was established by Andrews et 
al (1984) and was termed NTERA2. Andrew's group (1984) took TERA2 cultures and 
passaged them through an athymic (nu/nu) (nude) mouse. This resulted in the formation of a 
xenograft tumour containing glandular structures, mesenchyme and neural elements, as well 
as areas of EC cells. Both the TERA2 and NTERA2 cell lines have been shown to form 
well differentiated teratomas when transplanted into suitable hosts (Andrews 1984). Clones 
isolated from both TERA2 and NTERA2 cell lines have been shown to respond to retinoic 
acid and other agents in culture yielding both neurons and other non-neural cell types 
(Andrews 1984). However, the aim to create a pure EC cell line was not entirely reached. 
The NTERA2 cell line also contained contaminants, such as multiple cell types, most 
frequently being the glandular structures and neural elements found along-side the EC cells 
in the tumour. To combat this contamination problem single cell clones of NTERA2 were 
isolated, forming the widely used NTERA2 clone D l (often abbreviated to NT2/D1). This 
clone was made up purely of EC cells with no contaminants. Cells were extracted from a 
xenograft tumour containing NTERA2 EC cells, then single cells were isolated using a 
micropipette from a suspension of trypsinized cells (single cell selection). The single cell 
was then transferred into a well of a 24 well plate. Small colonies were then derived from 
this well then cultured up slowly to form the NTERA2 clone D l cell line (Andrews et al 
1984). 
The NTERA2 cell line and it's subsequent sub-lines express a range of characteristic surface 
antigens associated with other human EC cell lines such as 2102Ep, these include the 
antigens SSEA-3, SSEA-4, and TRA-1-60, a keratan-sulphate-associated glycoprotein 
antigen. NTERA2 EC cells also respond well when exposed to different agents in their 
culture media and induce differentiation. For example, NTERA2 EC cells commit to 
differentiation after only 1-2 days of exposure to retinoic acid. This was deduced since after 
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exposure to retinoic acid the cells rapidly lost their expression of the characteristic EC cell 
markers SSEA-3 and SSEA-4, and gained the expression of other cell surface antigens 
associated with the neural lineage, such as A2B5, a ganglioseries antigen (Andrews et al 
1990). NTERA2 EC cells can also be induced to differentiate into distinct non-neuronal cell 
types by H M B A and by bone morphogenetic protein-7 (BMP7) (Andrews et al 1994). These 
findings therefore overcame arguments that NTERA2 EC cells are restricted to neuronal 
differentiation, however it is known that neuronal differentiation in this particular cell line is 
marked and the cell line can therefore be used as a valuable experimental tool for the study 
of neurogenesis (Przyborski et al 2000) (Figure 1.10). 
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Figure 1.10: 
Human EC cells and their differentiated derivatives: A: 2102Ep EC cells B: NTERA2 EC cells C: 
NTERA2 cells after exposure to retinoic acid, have formed neurons. D: Cultures of purified neural cells. 
Scale bars A,B,D: 25pm C:330pm. (Courtesy of Dr SPrzyborski) 
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• NTERA2 Differentiation: The Effect of Retinoic Acid and 
Hexamethylene Bisacetamide 
Retinoic acid: 
The study of EC cell differentiation has uncovered many details concerning the regulation 
and mechanisms involved in cell differentiation during mammalian development. As 
previously mentioned EC cells can be induced to differentiate with the introduction of 
certain chemicals into the growth media. Retinoic acid is one of the most effective chemicals 
to induce TERA2 EC cells and its sub-lines to differentiate. Retinoic acid is a derivative of 
vitamin A and is known to induce differentiation in many different cell types such as 
epithelial and cancer cells. It is also known to play an important role in the development of 
the central nervous system in the mammalian embryo, which may partly explain why it 
induces TERA2 EC cells to differentiate into neural-type cells. The effects seen after 
exposure of EC cells to retinoic acid are thought to be mediated by the interactions of cell 
ligand-receptor complexes with specific DNA response elements, such as the retinoid X 
response elements (Leid et al 1992). It is thought that such interactions result in the 
production of signalling pathways inside the cell causing them to alter the normal pattern of 
gene expression, and ultimately inducing the cell to undergo differentiation. EC cells 
express hox genes in response to retinoic acid induced differentiation. The most predominant 
being the 4.2 kB transcript of Hox 5.1, which otherwise is almost exclusively found in the 
central nervous system of the developing human embryo, therefore supporting the notion 
that retinoic acid induces neural derivatives from EC stem cells (Simeone et al 1990). 
Using the human TERA2 cell line Andrews' group studied the glycolipids of the EC cells 
and their changes during chemically induced differentiation using retinoic acid as the 
inducing agent (Andrews et al 1990). This was achieved using monoclonal antibodies 
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specific to certain cell surface antigens. The study revealed that during and after 
differentiation induced by retinoic acid the expression of cell surface glycolipids undergo 
marked changes. The glycolipid antigens SSEA-3, SSEA-4 and TRA-1-60 (high molecular 
weight glycoproteins), which are expressed almost exclusively by pluripotent stem cells, are 
replaced on differentiated cells by lactoseries antigens such as SSEA-1, and ganglioseries 
antigens such as GT and 9-0-acetyl GD, which are recognised by the monoclonal antibodies 
A2B5 and Me311 respectively. Differentiated NTERA2 derivatives also express the 
monoclonal antibody VTN-IS-56, which is thought to recognize NCAM. 
Further analysis of the differentiated cells shows that the different subsets of the cells can 
express different patterns of these antigens. For example, EC cells which have been exposed 
to retinoic acid over a long period of time (> 3 weeks), tend to form mature neurons. These 
neurons express the A2B5 antigen but not the ME311 or SSEA-1 antigen, indicating that 
A2B5 could be used as a neural marker of EC cell differentiation (Andrews et al 1990, 
Przyborski et al 2000). Indeed, A2B5 has been linked with neuronal cells (Eisenbarth et al 
1979) however; there is no evidence of glial formation in the NTERA2 lineage (Andrews et 
al 1984). 
Neurons derived from NTERA2 EC cells have been extensively studied. They have been 
shown to express all three of the neurofilament proteins, which are associated with the N -
methyl-D-aspartate (NMDA) and non-NMDA glutamate receptor channels found in 
functioning neurons (Lee and Andrews 1986). The neural cells have also been shown to 
express muscarinic acetylcholine receptors and they are reported to be sensitive to glutamate 
excitotoxicity (Andrews 1998). Functional analysis has also concluded that the neurons 
produced are indeed functioning neurons capable of conducting electrical impulses (Rendt et 
al 1989). The neurons formed have been shown to bare closer relationship to embryonic 
neurons from the central, rather than peripheral nervous systems (Andrews 1998). The 
neurons created from the differentiation of NTERA2 EC cells have been reported to respond 
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to specific environmental cues to develop into distinct different types of neuron. For 
example, when the differentiated neurons were transplanted into different areas of a brain in 
immunodeficient mice the NTERA2-differentiated neurons took on the similar cell 
characteristics associated with the site of implantation ( Kleppner et al 1995). 
Other Inducers of E C stem cell differentiation: 
Although the predominant differentiation pathway of NTERA-2 cell lines appears to be 
neuronal, the human EC cells can also be induced to follow other differentiation pathways 
when exposed to different inducing agents such as 5-bromouracil 2'deoxyribose (BUdR), 5-
iodouracil 2'deoxyribose (IUdR), dimethylsulfoxide (DMSO) and hexamethylene 
bisacetamide (HMBA) (see below). The differentiation with each of the inducing agents was 
accompanied by the loss of the EC cell markers SSEA-3 and SSEA-4, however the antigen 
profiles seen after differentiation was significantly different from the profile obtained from 
retinoic acid-induced differentiated cells (Andrews et al 1986). For example, the antigen 
A2B5 appears in 60%-80% of NTERA2 cells differentiated with retinoic acid, but was 
detected in less than 20% of the cells induced by the other agents, therefore suggesting that 
the differentiated cells produced are different than the ones produced after exposure to 
retinoic acid (Andrews et al 1986). Andrews also showed that this has been revealed in EC 
cells induced to differentiate with DMSO, they appear to form muscle-like cell types as 
apposed to neural cell types seen after exposure to retinoic-acid. 
Hexamethylene Bisacetamide: 
HMBA-induced differentiation of NTERA-2 EC cells creates fully differentiated cells that 
appear similar to those non-neural cells induced by retinoic acid differentiation. They form 
homogeneous flat regular colonies when cultured in tissue culture plastic (Andrews et al 
1986). It is not known whether HMBA induces the same form of differentiation as retinoic 
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acid. As mentioned, changes in cell surface antigen expression and glycolipid composition is 
studied using monoclonal antibodies. Differences in surface antigen expression reflects 
differences between the different subsets of differentiated cells. Comparisons of the surface 
antigen expression between retinoic acid induced and HMBA induced differentiated cells 
indicate that differentiation occur along distinctly different differentiation pathways 
(Andrews et al 1990). Further to this, cultures of HMBA induced differentiated EC cells 
have shown no significant evidence for the production of neuronal cell types, (Andrews et 
al 1986) suggesting that HMBA initiates a separate pathway of differentiation than that 
induced by retinoic acid. Currently, the identity of the HMBA-induced differentiated cells 
remains unknown. 
• Human TERA2.SP12 Pluripotent Embryonal Carcinoma Stem Cells 
It is known that there is a wide variation between different clonal lineages of human EC 
lines. This is noticeable when looking at the fact that different lines have different optimal 
culture conditions, and also a variable capacity for differentiation. This varying 
differentiation between EC cell lineages means that different clones may be useful for 
different areas of research. For example, the NTERA2 sub-line differentiates into a variety 
of cells including neurons (roughly 10% of the total differentiated population) making it a 
useful tool for the study of neurogenesis (Przyborski et al 2000). However, under these 
growth conditions, no evidence of glial development was observed (Andrews 1984). Due to 
this fact Przyborski (2001) established a new sub clone of the TERA2 cell line termed 
TERA2.SP12. The idea behind this was that it may have a different capacity for 
differentiation and could therefore be used as a research tool in other fields of biology. The 
original TERA2 parent lineage is heterogeneous and contains a minor (1-2%) population of 
true EC cells and is therefore hard to use as a viable tool for research. Przyborski (2001), 
40 
developed a novel strategy to isolate and clone new lineages of human EC cells from mixed 
cell populations, including the TERA2 lineage, producing the TERA2.SP12 lineage. 
In brief, TERA2.SP12 human EC stem cells were derived from the earliest available passage 
of the original TERA2 parent lineage. Immunomagnetic isolation and single cell selection 
were used to obtain this new clonal EC line. Suspensions of TERA2 (pi5) EC cells were 
incubated with SSEA-3 antibody, a marker of EC cells. SSEA-3 positive cells were then 
isolated using direct positive magnetic separation. Isolated cells were immediately 
resuspended then magnetically separated for a second time to increase purity. The isolated 
EC cells were again resuspended then single cells were picked at random using a 
micropipette under a dissecting microscope. The single cells were then transferred to their 
own well of a tissue culture plate and expanded to form colonies of cloned EC cells. Clone 
TERA2.SP12 was selected for further analysis. The further analysis of the cells involved 
using a variety of techniques including cell cytometry, immunocytochemistry, 
immunofluorescent flow cytometry, northern analysis and western analysis, which all 
confirmed that the cells were indeed EC cells (Przyborski 2001). TERA2.SP12 EC cells 
were shown to have the capacity to differentiate in a slightly variable way to existing EC 
cell lines including TERA2 and NTERA2. TERA2.SP12 EC cells are capable of 
differentiating into both neuronal and glial lineages (Przyborski 2001), where as the existing 
lines only appear to differentiate into neurons. TERA2.SP12 human EC cells are currently 
used to research the formation of human neuronal and glial derivatives in our laboratory. 
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1.3 Aims of This Investigation 
1.3.1 Embryonal Carcinoma Stem Cells as a Model for Cell Fate 
Determination in the Human Ectoderm 
As this overview of EC cells has demonstrated, EC cells are very useful tools as cell-based 
systems for the study of embryogenesis in vitro. Whilst it has been extensively documented 
that cultured EC cell populations can be induced to form neural cell types, such as with 
retinoic acid, there is little evidence for the formation of epidermal derivatives. As a result 
of this I propose to investigate the potential of TERA2.SP12 EC stem cells to form neural 
AND epidermal tissues under different culture conditions. Previous studies in our 
laboratory have produced preliminary data indicating the potential for epidermal 
differentiation by TERA2 cultures. For example, a large-scale microarray study revealed 
that cultures of human EC cells formed neural cell types and also expressed some 
epidermal markers under alternative growth conditions (Przyborski et al 2001, 2003). 
When EC cell populations are exposed to H M B A the expression of high levels of mRNA 
for keratin, fibronectin and BMPs associated with epidermal differentiation are seen. I aim 
to extend these earlier observations and develop a model system that can be used to 
research the differentiation of the human ectoderm along neural and epidermal pathways. 
Subsequent to this, it would also be of value to more fully characterise the identity of the 
differentiated end products produced when EC cells are exposed to HMBA as this is 
currently unknown and there is very little evidence of neural differentiation in these 
cultures. 
The characterization of two alternative pathways of ectodermal differentiation wil l be of 
value to the study of the fundamental processes of cell fate determination in the human 
ectoderm. This could lead to the potential development of a culture system able to study 
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the epidermal differentiation from pluripotent stem cells along side the existing culture 
system used to study neural development by human EC cells. These two systems could be 
advantageous to the study of molecular mechanisms specifically involved in certain 
pathways of differentiation, for example, the involvement of molecules that are known to 
suppress the formation of neural derivatives. 
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Chapter 2: 
Experimental Approach 
2.1 Cell Culture: 
Human TERA2.SP12 EC stem cells were maintained at high density as previously described 
(Przyborski 2001). Briefly, to retain an optimum EC cell phenotype TERA2.SP12 cells were 
cultured in tissue culture flasks (Nunc) using Dulbecco's modified Eagle's medium 
(DMEM) supplemented with 10% foetal calf serum and 2mM L-glutamine under a 
humidified atmosphere of 5% C O 2 in air at 37°C. TERA2.SP12 cells were passaged when 
fully confluent, every 3-4 days, using glass beads and underwent a 1:3 split. The medium 
was changed twice weekly. 
TERA2.SP12 EC cells were induced to differentiate with either the introduction of retinoic 
acid (10(JM) (Sigma) or HMBA (3mM) (Sigma) into the media. In preparation for 
differentiation, confluent monolayers of TERA2.SP12 EC cells were treated with 0.25% 
trypsin in versene solution (1000ml Phosphate buffered saline with 0.2g EDTA and 3ml 
0.5% phenol red solution) for 2/3 minutes to produce a single cell solution. The suspended 
stem cells were counted using a haemocytometer and then seeded at 1.5xl06 cells per T75 
tissue culture flask in DMEM containing either retinoic acid or HMBA using the 
concentrations stated above. The media containing the differentiation inducing agent was 
changed twice weekly. Cultures treated with retinoic acid and HMBA were maintained for 
up to 4 weeks. 
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RNA and protein were harvested from cells after 1,2,and 4 weeks of differentiation. In brief, 
differentiated cells were harvested with 0.25% trypsin/versene solution to obtain a single 
cell suspension. The cells were counted then spun down using a centrifuge. The cell pellet 
was resuspended in sterile phosphate buffered saline (PBS) then stored in Eppendorf tubes 
of known cell numbers at -80 °C until required. 
TERA2.SP12 stem cells and their retinoic acid and H M B A induced derivatives were also 
grown on glass coverslips (16mm diameter). Cultures of the TERA2.SP12 stem cells were 
trypsinised and counted as described above, and 0.2xl0 6 cells were suspended in 4ml of 
media per well on a six well plate, each well containing 2 coverslips. Poly-D-lysine 
(0.lug/ml) was used to coat the glass coverslips overnight prior to seeding cells. Retinoic 
acid (lOiiM) or HMBA (3mM) was added to the wells to induce differentiation as before. 
The media was changed twice weekly and the cells incubated with the agents for up to 4 
weeks. 
TERA2.SP12 stem cells were also grown as aggregates in bacteriological dishes (VWR 
International). Cultures of the TERA2.SP12 stem cells were trypsinised and counted as 
described above, and 1.5xl0 6 cells were suspended in 25ml of DMEM media plus either 
retinoic acid ( lOf jM) or HMBA (3mM) per plate. Medium was changed every 3 1/2 days 
and the cells were suspended in new bacteriological dishes each time. After an incubation 
period of 3 weeks the aggregates were either harvested for RNA and protein as previously 
described, or were seeded onto coverslips coated with poly-d-lysine also described above. 
The media was changed twice weekly and the cells were incubated with the agents for a 
further 3 weeks. 
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2.2 Analysis of Cell Surface Antigen Expression: Flow 
Cytometry: 
Flow cytometry was used to analyse the changes in cell surface antigen expression before 
and after the differentiation of TERA2.SP12 cells in response to either retinoic acid or 
HMBA as described. The expression of cell surface antigens has been used previously to 
indicate the status of cellular differentiation by human pluripotent TERA2.SP12 stem cells 
(Przyborski 2001). 
Table 2.1: 
Antibodies used for cytometric analysis of TERA2.SP12 stem cells and their differentiated 
derivatives. All antibodies were diluted as indicated in wash buffer (PBS (without 
Ca2+/Mg2+) and 0.1% bovine serum albumin (BSA) and 0.1% sodium azide, pH 7.0). 
Primary antibodies were generously provided by Prof. P. Andrews, University of Sheffield, 
whilst the secondary antibody was obtained from Cappell, USA. 
Primary 
antibodies | 
IgG P3X(1:5) IgM |P3X(1:5) 
SSEA-4, a globoseries 
glycolipid antigen (1:2) 
SSEA-3, a globoseries 
glycolipid antigen (1:5) 
VTNIS-53, recognises 
NCAM(1:5) 
TRA-1-60, akeratan-
sulphate-associated 
glycoprotein antigen (1:5) 
Me311, a ganglioseries 
antigen (1:2) 
A2B5, a ganglioseries 
antigen (1:2) 
Secondary 
antibodies 
a-mouse-IgG-FITC (1:20) a-mouse-IgM-FITC (1:20) 
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Procedure: 
1) 1ml 0.25% trypsin/versene solution was used to create a single cell suspension of EC 
cells or their differentiated derivatives. Cell number was determined using a 
haemocytometer. 
2) Suspended cells were pelleted and resuspended in wash buffer. 0.2x106 cells in a 
200|LIL volume was added to the appropriate number of wells in a 96 well plate. The 
plates were lightly centrifuged and the supernatant removed, resulting in a cell pellet 
in the bottom of each well. 
3) 50pl of primary antibody (see Table 2.1) was incubated with the pellets for 1 hour at 
4°C. 
4) The primary antibody was removed with 3 washes in wash buffer. 
5) 50p.l of secondary antibody (see Table 2.1) was incubated with the cells for 30 
minutes at 4 °C. 
6 ) The secondary antibody was removed with 3 washes in wash buffer. 
7) Cell pellets were resuspended in 500^1 of wash buffer with lOfil of propidium iodide 
(0.25mg/ml, diluted 1:50 for use), to pick out any dead or dying cells when run 
through the flow cytometer. 
8) The samples were passed through the flow cytometer (Coulter XL) and cytometric 
traces were recorded for each of the primary antibodies tested. Thresholds 
determining the number of positively expressing cells were set against the negative 
control P3X before levels of specific cell surface antigen were determined. 
9 ) Viable, healthy cells were selected by the cytometer for investigation to eliminate 
false positive or negative results. This was done by the selection of cells that were 
the correct diameter, 10(.im, the idea being to avoid cell debris. These cells were 
gated then from these gated cells, cells were selected that were propidium iodide 
positive for reasons stated above. 
10) Cytometric analysis was carried out on three separate batches of cultured cells that 
were treated separately as individual experiments. 
2.3 Protein Expression Profiling Using Western Blot: 
Protein samples were harvested from TERA2.SP12 stem cells and their differentiated 
derivatives in preparation for western blot analysis. 
Table 2.2 
Antibodies used for western analysis ofprotein expression in TERA2.SP12 stem cells and 
their differentiated derivatives: All antibodies were diluted in blocking buffer (5% milk 
powder in TBS (Tris buffered saline) (1 OX solution: 6.1g tris base, 43.8g NaCl, 500ml H2O, 
pH 7.5) and 0.02% tween). 
Primary Antibody Clone Isotype Dilution factor 
(3-actin (Sigma) AC-15 Mouse IgG 1:1500 
NF-68 (Sigma) NR4 Mouse IgG 1:2000 
NSE (Chemicon) - Mouse IgG 1:2000 
Keratin (Chemicon) 
- Mouse IgG 
1:500 
Cytokeratin-8 M20 Mouse IgG 1:7000 
(Sigma) 
Secondary 
Antibody 
Clone Isotype Dilution factor 
Anti-mouse Ig-horse - Mouse IgG 1:1000 
radish peroxidase 
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Procedure: 
1) Protein samples were lysed in igepal lysis buffer (for 1ml: 10|il igepal (Sigma) 50ul 
1M tris (pH8), 50^1 3M NaCl, 1 MgCl 2 , 896^1 dH 2 0) containing protease 
inhibitors (Complete mini protease inhibitor cocktail, Roche Molecular 
Biochemicals). The resulting protein solutions were centrifuged at 15000 rpm for 3 
minutes and the supernatant transferred to a fresh tube. 
2) Protein concentrations were determined using the Bradford-based assay. 2ul of 
sample was added to 798fil dH^O and 200(0.1 of the BioRad solution. The 
concentrations were calculated against a standard calibration curve which had been 
set up using BSA standards using the UV spectrometer (see Figure 2.1). The 
volumes of the samples were then adjusted according to requirement. 12ug of sample 
was diluted in 12jal of loading buffer (5X stock: 2.5ml 1M Tris pH 6.8, 5ml glycerol, 
l g SDS, 0.05g bromophenol blue, 2.5ml 2(3-mecapto-ethanol) per well on the 
polyacrylamide gel. 
3) SDS-polyacrylamide gels were then prepared using the BioRad minigel system. 10% 
acrylamide gels were used as the separating gel since it was concluded the most 
appropriate density to study the separation of the particular proteins of interest. 
4) A 4% acrylamide stacking gel was subsequently poured and polymerised on top of 
the separating gel. 
5) The protein samples (1 ng/f-il) suspended in the loading buffer were denatured for 3 
minutes at 96°C. 
6) The samples were loaded onto the gel and electrophoresed at 200v for 35-45 minutes 
until the dye front had reached the bottom of the gel. 
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Figure 2.1. 
Graph of the protein standards used to determine concentration of the protein samples 
from TERA2.SP12 cells and their differentiated derivatives. Protein concentrations 
(fig/ml) were calculated using a standard curve made up using BSA protein standards. 
The readings were taken off the graph after absorbance had been determined (arrows). 
The calibration curve was taken from the UV spectrometer. 
Protein calibration curve 
0.8 
0.6 
8 10 12 14 16 18 20 
Concentration (microgrammes/ml) 
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7) The separated proteins were then transferred to PVDF membrane (Amersham) by 
electroblotting at lOOv for 1 !4 hours in towbin transfer buffer ( 3.03g tris-base, 
14.4g Glycine, 200ml methanol and 800ml dt^O) using the BioRad mini gel transfer 
apparatus. 
8) PVDF membranes (Amersham) were subsequently stained with Ponceau S solution 
(0.2% Ponseau S in 5% acetic acid) to check the quality of the transfer. The 
membranes were then left to dry. 
9) Rehydration of the membrane is required according to the manufacturers guidelines 
before it was blocked in blocking buffer (5% milk powder in TBS (10X solution: 
6.1g tris base, 43.8g NaCl, 500ml H 2 0 , pH 7.5) and 0.02% tween) for 1-2 hours at 
room temperature. 
10) The membrane was then incubated with the primary antibody (see Table 2.2), diluted 
in blocking buffer, for 1 hour at room temperature on a bench top rocker. (NB: 
Primary antibody titrations was carried out in all cases to determine optimal antibody 
dilution - see below) 
11) Primary antibody was removed by 3 washes in blocking buffer. Membranes were 
subsequently incubated with the secondary antibody (see Table 2.2), also diluted in 
blocking buffer, for a further 60 minutes at room temperature. 
12) Membranes were washed 3 times in TBS, followed by a final PBS wash. 
13) Antibody-antigen complexes were detected using chemiluminescence according to 
the manufacturers guidelines (Amersham). The luminescence signal was detected by 
f i lm photography (Hyperfilm ECL, Amersham). 
14) The intensity of the bands was analysed by routine densitometry using the BioRad 
Model GS-690 Imaging Densitometer. 
15) Al l results were reproduced using a second batch of cells grown independently. 
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Titration of Primary Antibodies: A titration blot was carried out i f the dilution factor 
of the primary antibody had not been predetermined. Gels were run containing 3 sets of 
the same samples, then various dilutions of the antibody were incubated with duplicate 
strips of membrane to determine which dilution factor obtained optimum results (see 
Figure 2.2). Then a ful l set of samples was run on a gel as described above and incubated 
with the determined dilution of antibody. 
Figure 2.2 
Typical example of a titration blot: The primary antibody was diluted 1:500, 1:1000 and 
1:2000, then incubated on the strips of membrane containing the equal loading of protein 
samples. Bands were seen to decrease in intensity with an increase of antibody dilution. In 
this instance, a dilution factor of 1:1500 was used for examining protein expression by 
western analysis. 
m 
1:500 1:1000 1:2000 
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2.4 Immunocvtochemistry: 
Cell cultures grown on glass coverslips were used for immunocytochemistry. 
Table 2.3 
Antibodies used to examine protein expression by immunocytochemistry: (All antibodies 
are diluted in staining buffer) 
Antibody Dilution factor 
Laminin (Sigma) 1:1000 
Fibronectin (Sigma) 1:1000 
NF-68 (Sigma) 1:400 
P-III-tubulin (Sigma) 
1:400 
1 Cytokeratin-8 (Sigma) 
1:500 
Keratin-14 (Chemicon) 1:500 
Secondary Antibody Dilution factor 
Anti-mouse IgG FITC (Sigma) 1:80 
Procedure: 
1) Cells grown on coverslips were either fixed in methanol or paraformaldehyde (PFA) 
according to the method for optimal antigen detection. 
Methanol-fixed: Cells were rinsed in PBS, then fixed in ice-cold methanol for 10 
minutes and stored along with a desiccant at -80°C until required. 
PFA-fixed: Cells were incubated with PFA (2% PFA in PBS) for 20 minutes then 
rinsed for 2 minutes in 3X PBS. Cells were dehydrated for 2 minutes consecutively 
in PBS, H 2 0 , 50% ethanol, 70% ethanol, 95% ethanol then finally 100% ethanol and 
stored at -80°C with a desiccant until required. 
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2) For immunocytochemistry, cells were incubated in blocking buffer ( 1 % BSA in PBS 
with 0.2% tween) for 1-2 hours at room temperature. 
3) The primary antibody (see Table 2.3) was then added, diluted in staining buffer 
(0.1% BSA in PBS with 0.2% tween), and left to incubate for 1 hour. 
4) The primary antibody was removed with 3 washes of 5 minutes each with staining 
buffer. 
5) The coverslips were then incubated with the secondary antibody (see table 2.3), 
diluted in staining buffer, for 1 hour at room temperature. 
6) The secondary antibody was then removed by a further 3 washes of staining buffer. 
7) The coverslips were then mounted onto microscope slides using Vectashield (Vector 
Labs), an aqueous mountant. 
8) Stained coverslips were examined using a fluorescence microscope (Axiovert 135) 
using the x5, xlO, x20, and x32 objectives. Phase contrast and their corresponding 
fluorescence images were collected using a combination of a digital camera (Nikon 
E5000) and standard 35mm f i lm camera (Nikon). 
9) A l l results were reproduced using a second batch of cells grown independently. 
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2.5 Analysis of Gene Transcription by RT-PCR: 
RT-PCR was used to detect the expression of certain genes. RNA samples were taken from 
cultures of TERA2.SP12 stem cells, their differentiated derivatives and differentiated 
aggregates grown on coverslips. RNA samples were used for RT-PCR analysis using 
specifically designed PCR primers. 
Table 2.4: 
List of PCR primers designed and used for RT-PCR analysis. All primers were 
manufactured by MWG, Germany. 
Human Gene Accession Number 
Optimal Annealing 
Temperature (°C) 
P-actin 1 BC009275 55.0 
M99435 
TLE1 | 
59.4 
TLE2 
M99436 62.0 
BMP4 
M22490 61.0 
BMP6 
M60315.1 54.8 
GATA-1 
NM_002049.1 61.3 
MSX1 
NM_002448 60.2 
SMAD1 
BC001878 54.7 
SMAD4 
N M 005359.2 48.9 
SMAD6 
NM_005585.2 63.6 
SMAD7 
N M 005904.1 62.7 
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Table 2.5 
List of appropriate PCR primer sequences and product size. 
Human 
Gene Primer Sequence 
Product 
size 
(bp) 
(3-actin 
For 
ATCTGGCACCACACCTTCTACAATGAGCTGC 803 
Rev CGTCATACTCCTGCTTGCTGATCCACATCTG 
T L E 1 
For TCATCGGGCAGCAGCAGTTG 
450 
Rev CATTTTCCCGGGGCGAGTTGG 
T L E 2 
For CGGGGCTGCTTGCTCTGTCT 
442 
Rev GTGCTGGCGGGAAGGTCATT 
BMP4 
For ACCCGGGAGAAGCAGCCAAACTAT 
553 
Rev AGCGGCACCCACATCCCTCTACTA 
BMP6 
For TGCCGGCTCTAGTACCTTTTCAGT 
430 
Rev GCCCGCCCACACCACGAC 
GATA-1 
For ACGACACTGTGGCGGAGAAATG 
439 
Rev 
TGAGCGGAGCCACCACAGTAGT 
MSX1 
For GTGGCGCCCGTGGGACTCTACA 
443 
Rev CACCGATTTCTCTGCGCTTTCTTG 
S MA 1)1 
For AAGCGTTCCATGCCTCCTC 
411 
Rev CTCCCCAGCCCTTCACAAA 
SMAD4 
For ATCCCTTAAAATTACCAGACAA 
462 
Rev TGCCCCAAGATACAAAAAC 
SMAD6 
For CGTGGGCCGCCTCTATGC 
480 
Rev CGCCGGGGCCGCCACTATCT 
SMAD7 
For AGGAGCGGCAGATGGGGAGACAAC 
453 
Rev AGAGGCTGAGGGGAGAGGGCACTG 
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Procedure: 
1) Cell pellets were lysed and RNA extracted using TRI reagent (Sigma) following the 
instructions outlined by the manufacturer. 1ml of TRI reagent was used to lyse 5-
lOxlO 6 cells by repeated pipetting. Samples were then left at room temperature for 5 
minutes. 0.2ml of chloroform was added then samples were shaken for 15 seconds 
before standing at room temperature for 7 minutes. The resulting mixture was 
centrifuged at 12000g for 15 minutes at 4 °C. The colourless upper aqueous phase 
was transferred to a fresh tube and 0.5ml of isopropanol was added and the mixture 
allowed to stand for 7 minutes. The samples were centrifuged at 12000g for 10 
minutes at 4°C. The RNA precipitate formed a pellet on the side and bottom of the 
tube. The supernatant was removed and the RNA pellet washed by the addition of 
l m l of 75% ethanol. The mixtures are then centrifuged at 7500 Xg for 5 minutes at 
4°C. The supernatant was removed and the pellets air dried for 5-10 minutes. 50|il of 
ddH20 was added then the pellets stored at -20°C. 
2) Final preparations of total RNA samples were read on the UV spectrometer (Fisher) 
to determine the total yield and purity of the RNA. Total yield was calculated using 
the following equations. (RNA samples diluted in H2O): 
Concentration of RNA sample = 40x A 2 6 0 x dilution factor 
Total yield = concentration x volume of sample in millilitres 
The purity was calculated from the ratio of the readings at 260 nm and 280nm 
(A260/A280) . These calculations are measured with the RNA samples diluted in lOmM 
Tris-Cl pH 7.5. Pure RNA samples should have a ratio of 1.9-2.1. 
3) lOjxg samples of pure total RNA were run down a 1% RNAase-free agarose gel ( 1 % 
agarose in TBE running buffer and 0.02% ethidium bromide) to check for RNA 
degradation. The resulting images o f the RNA bands was obtained by using a 
transilluminator (Gel Doc 2000, BioRad). An example is shown in Figure 2.3. 
Figure 2.3. 
Typical example of pure non-degraded total RNA. Non-degraded total RNA samples 
have two distinct bands representing 28s and 18s ribosomal RNA. Smearing of these 
bands down the lane would indicate degradation of total RNA. 
1. EC cell sample 2. EC cells differentiated with retinoic acid after 4 weeks incubation 
3. EC cells differentiated with HMBA after 4 weeks incubation 4. Neurosphere 
4) Total RNA samples are reverse transcribed using the oligo-dT (15) primer 
(Promega). lp.1 of the primer was combined with the RNA sample and H2O was 
added to 25\i\. The resulting mixture is heated at 70°C for 10 minutes then ice cooled 
for a further 10 minutes. To each reaction was added 8ul x5 buffer, lp.1 0.1M DTT, 
5(j.l lOmM dNTP, luJ RNase H-RT, and 1 RNasin (All Promega). Each mixture is 
incubated at 37°C for 2 hours, denatured at 95°C for 5minutes then left to cool on 
ice. The resulting cDNA samples can then be stored at -20°C until required. 
1. 2. 3. 4. 
Bands 
indicating 
pure un-
degraded 
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5) PCR primers were designed using the Primer Select computer package (DNAStar) 
and purchased from MWG. Newly synthesized primers were diluted with ddPhO and 
used at a concentration of 20 pmol/ml. 
6) For the polymerase chain reaction, the following reagents were added to each 
reaction tube and overlaid with mineral oi l : 
PCR Master mix (Promega) 6.25p.l 
5' Primer 0.5p.l 
3' Primer 0.5uJ 
cDNA sample 1.5ial 
ddH 2 0 3.75 | i l 
Total 12.5p.l 
The following PCR reactions were then carried out using a Perkin Elmer thermal cycler: 
94°C 3 minutes 1 cycle 
94°C 1 minute " 
Optimal annealing temperature (see Table 2.4) 1 minute V 35-40 cycles 
72°C 2 minutes ^ 
72°C 10 minutes 1 cycle 
7) The PCR products were separated from the mineral oil then run down a 1% agarose 
gel as mentioned above. Again the DNA bands were visualised using the 
transillunimator (Gel Doc 2000, Bio Rad) and a printed record obtained. 
8) A l l results were reproduced using a second batch of cells grown independently. 
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Chapter 3 
Human Embryonal Carcinoma Cells as a Model of Cell 
Fate Determination 
3.1 Differentiation of TERA2.SP12 Embryonal Carcinoma 
Cells In Vitro 
Cultures of TERA2.SP12 EC stem cells were maintained at high confluency to maintain 
their pluripotent phenotype. In this state all cells remain undifferentiated and had a high 
nuclear to cytoplasmic ratio (Figure 3.1a). TERA2.SP12 EC stem cells were induced to 
differentiate by introduction of either retinoic acid (10|aM) or HMBA (3mM) into the culture 
media. Differentiated cells were morphologically identified after just 2-3 days. In response 
to the addition of retinoic acid, TERA2.SP12 EC cells differentiated into a heterogeneous 
culture consisting of numerous cell types. Four weeks after introduction of the retinoic acid, 
terminally differentiated neurons expressing neurites were clearly visible by phase 
photography (Figure 3.1b). In response to HMBA, TERA2.SP12 EC cells differentiated into 
cells that displayed a large flat phenotype that was seen throughout the entire culture (Figure 
3.1c). Many of these large regular cells had a distinct phase bright outline, which may 
indicate the presence of extra-cellular material. In general, there was almost a complete lack 
of any visible neural cell types within the HMBA-induced cultures, even after 4 weeks of 
incubation. Very rarely there appeared to be 1 or 2 neurons observed in older cultures. This 
differs significantly from when the EC cells were differentiated with retinoic acid, since 
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roughly 10-20% of the cells in retinoic acid-induced cultures formed morphologically 
identifiable neurons. Based on their morphological phenotype, there appeared to be a lot of 
similarity between the phase-bright non-neuronal cells observed in both retinoic acid and 
HMBA-induced cultures. 
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F I G U R E 3.1: Phase contrast images of TERA2.SP12 human EC cells and their 
differentiated counterparts, a) TERA2.SP12 EC stem cells were maintained at high 
confluency. Note the high nuclear to cytoplasmic ratio, b) TERA2.SP12 EC cells after 4 
weeks exposure to 10pM retinoic acid. Cells have differentiated into a heterogeneous 
culture consisting of numerous cell types including neurons expressing neurites 
(arrows). Non-neural cells were observed beneath the neuronal cell types, c) 
TERA2.SP12 EC cells after 4 weeks exposure to 3mM HMBA. Differentiated cells have 
a large flat phenotype with a phase bright outline (arrows) which is consistent 
throughout the culture. 
a) 
b 
c) 
3.2 Regulation of Cell Surface Protein Expression during 
TERA2.SP12 Differentiation: 
Differentiation of TERA2.SP12 stem cells was monitored using flow cytometry. Antibodies 
against cell surface markers specific for stem cells (SSEA-3, SSEA-4, globoseries glycolipid 
antigens, and TRA-1-60, a keratan-sulphate-associated glycoprotein antigen) and markers 
for terminal neuronal differentiation (A2B5, a ganglioseries antigen, VINIS-56, which 
recognises NCAM, and Me311, also a ganglioseries antigen) were used to monitor protein 
expression. For each antibody used, graphical traces were obtained showing the intensity 
and quantity of fluorescence from which the percentage of positively stained cells within the 
sample was calculated (Figures 3.2-3.4, 3.6-3.8). From these data, graphs showing the 
profiles of protein expression during EC cell differentiation were produced (Figures 3.5 and 
3.9). The percentage of EC cells expressing the markers SSEA-3, SSEA-4 and TRA-1-60 
before differentiation was 90%, 98% and 98% respectively. Cytometric data clearly 
indicates a down regulation of the stem cell markers when the TERA2.SP12 EC cells are 
exposed to either retinoic acid or HMBA. After only 1 week exposure to retinoic acid the 
proportion of cells expressing the markers had decreased to 10%, 96% and 30% and by 
week 4 were down to 2%, 2% and 3% respectively (Figure 3.5). After 1 week incubation 
with HMBA the percentage of positively fluorescing cells was 19%, 99% and 90% 
respectively, and by week 4 this had decreased to 2%, 11% and 6% (Figure 3.5). From these 
data it can be seen that the stem cell markers appear to be down regulated by cells 
differentiating in response to HMBA at a significantly slower rate than with those exposed 
to retinoic acid. However, in both cases the stem cell markers are almost completely absent 
by 4 weeks of differentiation. 
In contrast, proteins recognised by antibodies A2B5 and VINIS-56 were up-regulated during 
retinoic acid- and HMBA-induced differentiation of TERA2.SP12 cells (Figure 3.9). These 
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markers were detected at very low levels on the EC stem cells (4% A2B5 and 6% VTNIS-
56). After 4 weeks exposure to retinoic acid both A2B5 and VINIS-56 were up-regulated to 
97%, indicating that the TERA2.SP12 cells had responded to the inducing agent. The cell 
surface markers A2B5 and VINIS-56 are also thought to be associated with detecting the 
neural lineage (Eisenbarth et al 1979, Andrews et al 1996). Accordingly, the up-regulation 
of A2B5 and VINIS-56 appears to correlate with the differentiation of identifiable neurons. 
In contrast, after 4 weeks incubation with HMBA the level of A2B5 and VTNIS-56 
expression had increased by 17% and 31% respectively. The expression of A2B5 and 
VTNIS-56 in H M B A induced cultures is significantly less than in retinoic acid treated 
cultures, which may reflect their different capacities for neuronal differentiation. The 
ganglioseries cell surface antigen recognised by Me311 showed minimal regulation by either 
inducing agent, indicating that during these two distinct pathways of differentiation an up-
regulation of this antigen is not induced. 
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Figure 3.2: Cytometric traces showing the expression of cell surface markers. Traces showing the 
change in expression of the stem cell marker SSEA-3 after differentiation ofTERA2.SP12 EC cells 
with either retinoic acid (lOfjM) or HMBA (3mM) over a period of 4 weeks. Percentage value 
indicates the proportion of cells positively expressing SSEA-3. (x-axis^Intensity of cells expressing 
SSEA-3, y-axis=number of cells flourescing) 
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Figure 3.3: Traces showing the change in expression of the stem cell marker SSEA-4 after 
differentiation of TERA2.SP12 EC cells with either retinoic acid (lOfiM) or HMBA (3mM) over a 
period of 4 weeks. Percentage value indicates the proportion of cells positively expressing SSEA-4. 
(x-axis ^Intensity of cells expressing SSEA-4, y-axis=number of cells flourescing) 
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Figure 3.4: Traces showing the change in expression of the stem cell marker TRA-1-60 after 
differentiation of TERA2.SP12 EC cells with either retinoic acid (10/uM) or HMBA (3mM) over a 
period of 4 weeks. Percentage value indicates the proportion of cells positively expressing TRA-1-
60. (x-axis=Intensity of cells expressing TRA-1-60, y-axis=number of cells flourescing) 
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F I G U R E 3.5: Overview of the expression of cell surface stem cell markers during 
cellular differentiation. TERA2.SP12 EC cells were exposed to either a) retinoic 
acid (10 pM) or b) HMBA (3mM). Data were determined by flow cytometry. These 
figures represent typical data trends seen in all 3 separate data sets. 
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Figure 3.6: Traces showing the change in expression of the differentiation marker A2B5 after 
differentiation of TERA2.SP12 EC cells with either retinoic acid (WfiM) or HMBA (3mM) over a 
period of 4 weeks. Percentage value indicates the proportion of cells positively expressing A2B5. 
(x-axis=Intensity of cells expressing A2B5, y-axis=number of cells flourescing) 
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Figure 3.7: Traces showing the change in expression of the differentiation marker VINIS-56 after 
differentiation of TERA2.SP12 EC cells with either retinoic acid (lOjiM) or HMBA (3mM) over a 
period of 4 weeks. Percentage value indicates the proportion of cells positively expressing VINIS-
56. (x-axis=Intensity of cells expressing VINIS-56, y-axis=number of cells flourescing) 
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Figure 3.8: Traces showing the change in expression of the differentiation marker Meill after 
differentiation of TERA2.SP12 EC cells with either retinoic acid (10/jM) or HMBA (3mM) over a 
period of 4 weeks. Percentage value indicates the proportion of cells positively expressing Me311. 
(x-axis=Intensity of cells expressing Me311, y-axis=number of cells flourescing) 
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F I G U R E 3.9: Overview of the expression of the differentiation markers during 
cellular differentiation. TERA2.SP12 EC cells were exposed to either a) retinoic 
acid (10pM) or b) HMBA (3mM). Data were determined by flow cytometry. These 
figures represent typical data trends seen in all 3 separate data sets. 
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3.3 Protein Expression Profiling during Embryonal Carcinoma 
Differentiation: 
Protein expression profiles of specific markers for neural and non-neural cell types, 
including epidermis, were determined using western blot analysis during the differentiation 
of human EC cells (Figure 3.10). Proteins known to be expressed in neural cell types were 
detected by antibodies specific for NSE and NF-68, and antibodies against non-neural 
proteins such as keratin, cytokeratin-8 were used in this instance as there band sizes were 
easily visualised on a 10% acrylamide gel. NSE was expressed to a much higher level with 
retinoic acid induced cultures than with HMBA induced cultures. In both cases the level of 
expression increased in relation to the number of weeks the cultures had been exposed to the 
differentiation-inducing agents. NF-68 also showed increased expression in response to 
retinoic acid, but no NF68 expression was detected in HMBA treated cultures. Markers of 
epidermal derivatives including keratin and cytokeratin-8 were also studied. A general 
marker of keratin was broadly reactive to all samples tested, showing a slight increase in 
expression levels in cultures exposed to HMBA. In contrast, cytokeratin-8, a more specific 
marker of epidermal keratin was differentially expressed in the treated samples. Cytokeratin-
8 was expressed at very low levels in the EC cells and showed a marked increased of 
expression in samples of differentiated cells. HMBA- treated cells showed significantly 
higher levels of cytokeratin-8 expression compared to those induced to differentiate by 
retinoic acid. 
Graphs were plotted of densitometry data obtained from studying individual band density 
using pixels (Figure 3.11) 
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F I G U R E 3.10: Profiles of protein expression were determined by western analysis 
during the differentiation of TERA2.SP12 EC cells in response to retinoic acid (RA) 
and HMBA. Markers for neural cell types were detected by antibodies specific for 
NSE and NF-68, whilst epidermal and extracellular matrix proteins were detected by 
keratin and cytokeratin-8. This analyses was preformed on 2 data sets, both of which 
produced similar results. B-actin was used as a loading control. 
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F I G U R E 3.11: Densitometric analysis of banding pattern from western blots 
showing profiles of protein expression during differentiation of TERA2.SP12 
EC cells. Graphs show plots for a) NSE b) NF-68 c) Keratin d) Cytokeratin-8 and 
e) fi-actin. This analyses was preformed on 2 data sets, both of which produced 
similar results. 
NSE 
a) 7 1 
6 
c 
5 
( f ) 
11 D 
EC R a w k l Pa wk 2 Rawk4 HMBA wk HMBA wk HMBA wk 
1 2 4 
NF-68 
b) 
0.35 
.2 0.25 
c 
E 
fe1 0.15 
0.05 
E C Ra wk 1 Ra wk 2 Rawk4 HMBA wk HMBA wk HMBA wk 
1 
F I G U R E 3.11: Continued.. 
Keratin 
C) 6 -l 
111 Mil 1 
! • 
EC R a w k l Rawk2 Ra wk 4 HMBA wk HMBA wk HMBA wk 
1 2 4 
Cytokeratin-8 
3.5 T 
9 2.5 
• • 
EC R a w k l Ra wk 2 Ra wk 4 HMBA wk HMBA wk HMBA wk 
1 2 4 
F I G U R E 3.11: Continued.. 
Beta-actm 
e) 8 
6.5 
2 
c 
2 
4.5 
E C Rawk4 HMBA wk HMBA wk HMBA wk Ra wk 1 Ra wk 2 
3.4 Immunofluorescence Localisation of Protein Markers 
during Embryonal Carcinoma Cell Differentiation: 
To back up the data produced from the western blot profiles more markers of neural and 
non-neural/epithelial cell types were analysed. More non-neural/epithelial cell markers were 
investigated, as looking at the morphology and western data produced it is possible that 
some of the non-neural cell types seen could be of a epithelial nature. The markers of neural 
proteins used were (3-tubulin-III and NF-68, and markers of non-neural/epithelial proteins 
were cytokeratin-8, fibronectin and laminin. Using immunofluorescent techniques neurons 
were identified by the marker P-tubulin-III, which was found to be expressed in distinct 
islands of neuronal cells in cultures induced to differentiate with retinoic acid. It was also 
possible to see neurites around the edge of the islands expressing P-tubulin-III. However, P-
tubulin-III expression was completely absent in HMBA-induced differentiated cells (Figure 
3.12). Cytokeratin-8, an epidermal associated marker, was expressed in significantly higher 
levels in samples induced to differentiate with HMBA than those induced to differentiate 
with retinoic acid (Figure 3.13). This observation is in agreement with the western analysis 
data. The fibronectin antibody recognises an extra-cellular protein associated with the extra-
cellular matrix. It has been associated with epidermal layer development (Grover et al 1983), 
however, it is not an exclusive epidermal marker, as it also stains mesenchyme. This factor 
has to be considered when interpreting the results obtained. In TERA2.SP12 cultures the 
expression of fibronectin also appears to be significantly increased in the cultures induced to 
differentiate with HMBA compared with the level seen in cells induced to differentiate with 
retinoic acid (Figure 3.14). It is also noted that there are differences in cell density between 
the figures shown in figure 3.14, this may have some affect on the level of fibronectin 
expression, as it is generally found to be up-regulated with increased density. Anti-laminin 
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shows immunoreactivity to laminin found in basement membranes. As well as fibronectin, 
laminin is associated with the formation of epithelial layers during development (Grover et 
al 1983). Again, HMBA treated cultures showed higher levels of laminin expression. Large 
thick tracks of laminin protein were visible compared to a fine network observed in retinoic 
acid treated cultures (Figure 3.15). 
TERA2.SP12 EC cells were also grown and induced to differentiate as aggregates. We have 
previously shown that when aggregates are kept in suspension and exposed to retinoic acid, 
roughly 95% of cells within the aggregate take on a neuronal phenotype (Stewart et al 
2003). HMBA aggregates have not previously been studied in this particular cell line. In this 
study aggregates induced to differentiate with either retinoic acid or HMBA were grown in 
suspension for 3 weeks followed by a further 3 weeks growth on coverslips. Aggregate 
formations were visualised in both cultures. Cells were stained for specific proteins 
indicative of certain cell types. Entire aggregates stained positive for p-tubulin-III in the 
retinoic acid induced samples. Some low level P-tubulin-III staining was picked up in the 
H M B A induced samples (Figure 3.16). High levels of cytokeratin-8 staining was detected in 
response to retinoic acid and HMBA but especially throughout retinoic acid-induced 
cultures (Figure 3.17). In addition, cells that had appeared to have spread away from the 
retinoic acid-induced aggregates showed intricate staining of cytokeratin-8 (Figure 3.17e). 
Retinoic acid-induced aggregates all stained positive for NF-68 whereas cells which had 
spread away from the main body of the aggregate were negative, suggesting that no new 
neuronal growth away from the aggregate was occurring (Figure 3.18). Very few cells 
stained positive for NF-68 in cultures grown as aggregates in the presence of HMBA 
indicating little neuronal growth. 
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F I G U R E 3.12: Immunocytochemical staining with fi-tubulin-UI of TERA2.SP12 EC 
cells after 4 weeks differentiation using either retinoic acid (a,b) or HMBA (c,d). 
Phase contrast image of retinoic acid induced differentiated EC cells (a) and the 
corresponding fluorescent image (b). Phase contrast image of HMBA-induced 
differentiated EC cells (c) and the corresponding fluorescent image (d). Note the 
presence of distinct islands of cells that express p-tubulin-III in retinoic acid induced 
differentiated cells (arrows on phase photograph) and the presence of neurites (arrow 
on fluorescent image). Few similar such structures and almost no p-tubulin-HI 
expression was observed in the HMBA induced cultures. Bars: 400pm 
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F I G U R E 3.13: Immunocytochemical staining using cytokeratin-8 on TERA2.SP12 
EC cells after 4 weeks differentiation using either retinoic acid (a,b) or HMBA (c,d). 
Phase contrast image of retinoic acid induced differentiated EC cells (a) and (b) 
corresponding fluorescent micrograph. Images show a typical region of non-neuronal 
cells induced by retinoic acid. Phase contrast image of HMBA-induced differentiated 
EC cells (c) and (d) corresponding fluorescent image. Note the higher expression 
level of cytokeratin-8, a marker of epidermal cells, in HMBA induced differentiated 
cells. This pattern was typical across the culture. Bar: 150pm 
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F I G U R E 3.14: Immunocytochetnical staining using fibronectin on TERA2.SP12 
EC cells after 4 weeks differentiation using either retinoic acid (a,b) or HMBA 
(c,d). Phase contrast image of retinoic acid induced differentiated EC cells (a) and 
(b) corresponding fluorescent image. Phase contrast image of HMBA-induced 
differentiated EC cells (c) and (d) corresponding fluorescent image. Note the 
increased intensity and quantity of staining in response to HMBA differentiation. 
This pattern was typical across the culture. Bar: 250/jm 
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F I G U R E 3.15: Immunocytochemical staining with laminin of TERA2.SP12 EC 
cells after 4 weeks differentiation using either retinoic acid (a,b) or HMBA (c,d). 
Phase contrast image of retinoic acid induced differentiated EC cells (a) and (b) 
corresponding fluorescent image. Phase contrast image of HMBA-induced 
differentiated EC cells (c) and (d) corresponding fluorescent image. Note the 
different expression patterns in the different cultures: Large amounts of laminin 
arranged in thick bands are seen in HMBA-induced cultures compared to a fine 
network of staining seen around the cells in retinoic acid induced cultures. This 
pattern was consistent across the culture. Bar: 250pm 
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To examine the degree of epidermal differentiation, keratin-14 was used to detect more 
mature epidermal structures. Under these culture conditions, staining for keratin-14 was 
negative in all samples of TERA2.SP12 cultures tested (Figure 3.19). A positive control 
sample of skin was also tested, the basement membrane and hair follicles showed high 
expression of keratin-14 indicating positive staining for the antibody (Figure 3.19e and f ) . 
When TERA2.SP12 EC cells were exposed to either retinoic acid or HMBA either as 
monolayer cultures or grown as aggregates, it was noted that cells which stained for markers 
of neural lineages, such as P-tubulin-III and NF-68 did not stain positively for the non-
neural markers fibronectin, cytokeratin-8 or laminin. This is best seen in figures 3.16 and 
3.18, where the larger, flatter-looking cells do not express the neural markers, whereas cells 
which are of a similar nature shown in figure 3.17 are positive for cytokeratin-8. 
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F I G U R E 3.16: Immunocytochemical staining with fi-tubulin-IH of differentiated 
TERA2.SP12 EC cells grown as aggregates. Cells were initially grown as 
aggregates for 3 weeks followed by 3 weeks growth on glass coverslips. Phase 
contrast image of retinoic acid induced (10pM) differentiated cells (a) and (b) 
corresponding fluorescent image. Phase contrast image of HMBA (3mM) induced 
differentiated cells (c) and (d) corresponding fluorescent image. Low power 
magnification image of (e) retinoic acid-induced cells and ( f ) HMBA-induced cells. 
Large numbers of neurons were observed in retinoic acid induced cultures whilst 
few were noted in cultures exposed to HMBA. The arrow indicates a possible 
neuritepresent in the HMBA aggregate cultures (arrows in c and d). Bar: (a,b,c,d) 
100pm and (e,f 200 pm 
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F I G U R E 3.17: Immunocytochemical staining with cytokeratin-8 of differentiated 
EC cells grown as aggregates. Cells were initially grown as aggregates for 3 weeks 
followed by 3 weeks growth on glass coverslips. Phase contrast images of retinoic 
acid induced (IOJJM) differentiated cells (a,c) and corresponding fluorescent image 
(b,d). Phase contrast image of HMBA (3mM) induced differentiated cells (e) and 
corresponding fluorescent image ( f ) . Fluorescent image (d) shows cells remote from 
the aggregate that have spread out forming large flat structures expressing 
cytokeratin-8. Note the presence of neurons expressing neurites in the HMBA 
aggregate cultures (arrow). Bar: (a,b,ej) 100pm and (c,d) 125pm 
F I G U R E 3.18: Immunocytochemical staining with NF-68 of differentiated 
TERA2.SP12 EC cells grown as aggregates. Cells were initially grown as 
aggregates for 3 weeks followed by 3 weeks growth on glass coverslips. Phase 
contrast image of retinoic acid induced (10pM) differentiated cells (a) and 
corresponding fluorescent image (b). Phase contrast image of HMBA (3mM) 
induced differentiated cells (c) and corresponding fluorescent image (d). Note that 
the expression of NF-68 ( a neural marker) is absent in the HMBA aggregates and 
expressed strongly in the retinoic acid cultures but only in the aggregate itself and 
not in the large flat cells away from the aggregate (arrow). Bar: 100pm 
F I G U R E 3.19: Immunocytochemical staining with keratin-14 (a mature 
epidermal marker) of differentiated TERA2.SP12 EC cells grown as aggregates. 
Cells were initially grown as aggregates for 3 weeks followed by 3 weeks growth 
on glass covers lips. Phase contrast image of retinoic acid induced (10 pM) 
differentiated cells (a) and corresponding fluorescent image (b). Phase contrast 
image of HMBA (3mM) induced differentiated cells (c) and corresponding 
fluorescent image (d). Control phase contrast image of a sectioned mammalian 
skin sample (e) and corresponding fluorescent image ( f ) (sample courtesy of Dr A 
Maatta). No significant expression of keratin-14 can be seen with either of the 
differentiated EC cell samples suggesting no mature epidermis being present. In 
contrast, strong expression of the antibody was seen associated with the 
suprabasal layers and hair follicles within the skin. Bar: (a,b,e,f) 100pm, (c,d) 
200pm. 
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3.5 Transcriptional Profiling of Differentiating Embryonal 
Carcinoma Cells: 
RNA was extracted from cultures of TERA2.SP12 stem cells and their differentiated 
derivatives and used to analyse the expression profiles produced of specific anti-neural 
genes and molecules involved in the bone morphogenetic protein signalling pathway by RT-
PCR. 
Anti-neural genes were examined to see i f the absence of neural cells within HMBA-
induced cultures occurred as a result of the activation of specific anti-neural pathways. The 
anti-neural gene del was expressed evenly throughout all the samples, whereas tie! was 
expressed in increasing intensity as the incubation period of the cultures with retinoic acid 
and HMBA increased (Figure 3.20a). 
As the differentiation patterns seen with TERA2.SP12 EC cells appear to represent those 
seen in the ectoderm of the developing human embryo, expression of specific regulatory 
proteins from this process were studied, namely those associated with the bone 
morphogenetic protein signalling pathway (reviewed in Weinstein and Hemmati-Brivanlou 
1999). Bone morphogenetic proteins (BMP) 4, and 6 were expressed in all samples tested 
(Figure 3.20b). Molecules which are found further down the BMP signalling pathway 
including, msxl, Smadl,4,6 and 7, also showed similar levels of expression under the 
different culture conditions. Interestingly, gata-1 expression was highly regulated, showing 
highest levels of transcription in cultures grown initially as aggregates in response to retinoic 
acid (Figure 3.20c). 
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F I G U R E 3.20: Transcriptional profiling of gene expression during TERA2.SP12 
EC cell differentiation as determined by RT-PCR. j3-actin was used as a 
loading/positive control in each case. The size of each amplified product agreed 
with values as expected. 
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3.6 Summary of Results 
TERA2.SP12 EC stem cells can be induced to differentiate along different pathways by 
exposure to either retinoic acid, HMBA, or by altering the culture conditions. Cells cultured 
as monolayers with retinoic acid appear to produce -10-20% neuronal type cells and -80-
90% non-neural cells. When the cells are grown as aggregates they produce >95% neuronal 
tissues when exposed to retinoic acid. However when these aggregates are grown on 
coverslips for prolonged periods, an increased level of non-neural cell types are seen. 
When cells are exposed to HMBA and grown as aggregates -95% of cells appear to take on 
a non-neural lineage, but a small percentage of cells also appear to take on a neural 
phenotype when the aggregates undergo extended growth on coverslips. In contrast, 
TERA2.SP12 cells grown as monolayers in the presence of HMBA take on a -99% non-
neuronal cell phenotype with neurons seldom being seen. 
In all cultures tested this non-neuronal cell type appears to be epithelial in character. 
A diagrammatical overview of the results obtained in this investigation can be seen in Figure 
3.21. 
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F I G U R E 3.21: General Overview of the Alternative Pathways of 
Cellular Differentiation during the Growth of Human TERA2.SP12 
EC Stem Cells Under Varying Cell Culture Conditions. 
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Chapter 4 
Discussion 
4.1 Neural and Non-neural Differentiation of T E R A 2 . S P 1 2 Embryonal 
Carcinoma Stem Cells 
The ability of human EC cells to differentiate into neural sub-types both spontaneously and 
in response to retinoic acid has been well documented. For instance, Pera et al (1989) 
demonstrated the ability of the germ cell tumour (GCT) derived EC cell line GCT 27 to 
differentiate spontaneously into many tissue types including neuroectodermal cells. The 
controlled differentiation of human EC cell lines in response to retinoic acid has also been 
extensively studied (Andrews et al 1984; Przyborski et al. 2000; Thompson et al 1984; 
Simeone et al 1990). In all cases similar morphological and phenotypical properties of 
neural-like cells were reported. More specifically, we have examined the neuronal 
development of a recently derived human EC cell line, TERA2.SP12. Upon the addition of 
retinoic acid to culture media, TERA2.SP12 EC cells have the capacity to differentiate and 
produce neural progenitors that ultimately express neurites (Przyborski 2001; Stewart 2003). 
These observations are consistent with data presented in this investigation. Here, when 
TERA2.SP12 EC cells were grown as monolayers and exposed to retinoic acid, 
approximately 10-20% of the cells appeared to follow the neural lineage. These neural like 
cells were observed to produce neurites after 4 weeks of incubation. Moreover, the nerve 
cells appeared to be sitting on top of a layer of non-neural cells, making this a heterogeneous 
culture. As mentioned above, such neural differentiation has been seen in other EC cell lines 
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in response to retinoic acid, including another sub-line of the TERA2 lineage, 
NTERA2.cl.Dl established by Andrews et al 1984. However, to date there has been little 
data concerning the identity of the non-neural cells found throughout the culture. 
After introduction of HMBA into the culture medium, TERA2.SP12 EC cells also appeared 
to differentiate, but along an apparently different differentiation pathway. The cells within 
the culture stopped proliferation and changed morphologically forming a homogeneous 
culture containing cells with a large, flat oval phenotype, covering the entire culture area. 
These cells were non-neuronal and were morphologically similar to those non-neural cells 
found under the neurons in retinoic acid induced cultures. Similar HMBA-induced 
differentiation have also been observed in the NTERA2.cl.Dl EC cell line (Andrews et al 
1990). Where it was noted that no significant neural differentiation occurred and the culture 
yielded a homogeneous layer of large, flat oval cells. The identity of such cells was not fully 
defined. HMBA as a differentiation-inducing agent has not been extensively studied in any 
other EC cell line. 
Differentiation of TERA2.SP12 EC cells in response to retinoic acid and HMBA was 
confirmed by the down regulation of cell surface markers specific to undifferentiated stem 
cells. These markers, namely SSEA-3, SSEA-4 and TRA-1-60 have also been shown to be 
down-regulated in the human EC cell line 2102Ep after differentiation has been established 
(Andrews et al 1982). There was also a significant increase in the cell surface markers 
associated with differentiated cells in both retinoic acid and HMBA-induced cultures. The 
most significant increase was with EC cells induced to differentiate with retinoic acid. This 
could be due to the fact that two of the differentiation markers used, A2B5 and VINIS-56, 
are thought to be associated with the neural lineage (Eisenbarth et al 1979, Andrews et al 
1996). The Me311 cell surface marker was not increased on any of the differentiated 
cultures. This observation was also consistent with the response by the NTERA2.cl.Dl EC 
cell line (Andrews et al 1990), indicating that the particular cell surface antigen that Me311 
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recognises is not affected by the differentiation of TERA2.SP12 EC cells induced by either 
retinoic acid or HMBA. 
Together these observations indicate that the introduction of retinoic acid or HMBA into a 
culture of TERA2.SP12 EC cells induces cellular differentiation in a manner that is 
conserved with other sub-lines of the TERA2 lineage. It also appears that neuronal cell types 
are present in retinoic acid-induced cultures, but are absent in HMBA induced cultures, 
suggesting that the differentiation pathway in each case is different. However when looking 
only at the morphology of the cells, it appears that some similarities are retained between the 
two cultures. The non-neural cell types found in retinoic acid induced cultures appear very 
similar to those found throughout the entire culture of cells exposed to HMBA. This 
observation has not been previously reported. 
When TERA2.SP12 EC cells were grown and differentiated as monolayer cultures it was 
observed that in retinoic acid induced cultures the expression of specific neural markers such 
as NF-68, NSE and (3-tubulin-III occurred at high levels, whereas in HMBA induced 
cultures the expression was minimal, again indicating that retinoic acid monolayer cultures 
contain neurons whereas HMBA monolayer cultures do not. This expression correlated with 
the morphological appearance of neurons and agreed with the analysis of cell surface 
markers carried out by Andrews et al. 1990 in the NTERA2.cl.Dl human EC cell line. In 
contrast, both HMBA and retinoic acid induced cultures expressed non-neural markers 
namely keratin, cytokeratin-8, fibronectin and laminin, which along with other non-neural 
cell lineages, are expressed by epithelia cells. Cytokeratin-8 has been shown to be a good 
marker of early epidermal cell lines produced from all of the germ layers, including the 
ectoderm, where the development of skin epidermis occurs, showing expression of such 
cells up to day 12 of embryonic development. After this time point, only epidermal cells 
from the mesoderm and endoderm initiate positive reactions with this antibody, and skin 
epidermis from the ectoderm does not (Kemler et al 1981). Since EC cells have the ability to 
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differentiate into all three of the germ layers, it can be assumed that the expression levels 
seen with cytokeratin-8 in this instance could indicate the presence of an early epidermal 
lineage from either of these germ layers. This could include early epidermal lineages 
originating from the ectoderm, which is what this investigation is interested in. A pan-
keratin marker also showed differential regulation. Both keratin markers revealed expression 
levels that were significantly higher in HMBA induced differentiated cells, suggesting that 
the introduction of HMBA into cultures of TERA2.SP12 EC cells may result in the 
differentiation of immature epidermal cell types. The expression of these markers is also 
seen at a lower level in retinoic acid induced cultures indicating that similar non-
neural/epidermal cells may be present. However, from the preliminary data obtained in this 
study it can not be said that all of the non-neural differentiation that occurs in these cultures 
are of an epithelial/epidermal nature as other cell types have not been looked for, and the 
non-neural markers used are not exclusive to epidermal lineages. Therefore, to establish the 
nature of all of the non-neural cell-types present more investigation into this area is required. 
Fibronectin, an extra-cellular matrix protein, and laminin, a protein found in basement 
membranes can both be used as markers of the development of epidermal epithelia (Grover 
et al 1983). In this study both proteins were seen to be expressed in HMBA induced cultures 
and also at lower levels in retinoic acid induced cultures, providing further evidence that 
some of the non-neural cell types found in both cultures are possibly epithelial and with 
further investigation could be found to be epidermal in nature. 
From these preliminary data it appears that when TERA2.SP12 EC cells are exposed to 
retinoic acid both neural and epithelial differentiation occurs whereas when the EC cells are 
exposed to HMBA it appears that only non-neural cells which could be epithelial 
differentiation results. This could indicate that during differentiation induced by HMBA a 
mechanism is present which inhibits neural differentiation. Two possible reasons for the lack 
of neurons found in HMBA cultures were considered. First, the default neural pathway 
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could be inhibited by the expression of anti-neural genes. Second, neural inhibition could 
occur by a mechanism similar to that found in the suppression of the default neural pathway 
modulated by BMP signalling during cell fate determination in the embryonic ectoderm. 
These hypotheses are discussed further below. 
Some of the differentiation profiles shown to occur in the TERA2.SP12 EC cell line in this 
investigation have been reported in studies carried out on human ES cells. Initial work 
carried out by Schuldiner et al 2000 on the controlled differentiation of human ES cells 
discovered that the introduction of retinoic acid into culture medium up-regulates the 
expression of markers for neural differentiation (neurofilament heavy chain) and skin 
epidermal differentiation (keratin), similar to the expression profiles seen in this 
investigation with the introduction of retinoic acid. HMBA has not been used to induce 
differentiation of human ES cells, however other epidermal inducing factors such as BMP4 
have been examined. In Schuldiner's study (2000) the introduction of BMP4 into culture 
medium resulted in the up-regulation of skin epidermal markers and an absence of neural 
markers, similar to the results obtained when TERA2.SP12 EC cells are induced to 
differentiate with HMBA. These findings add further basis to the argument that human EC 
cells represent a readily available, researchable model of human ES cells as previously 
reported (Andrews, 2001- book chapter reference). Reconstituted skin has been formed from 
murine embryonic stem cells (Coraux et al. 2003). These stem cells were grown on human 
normal fibroblasts as a feeder layer and exposed to either BMP-4 or ascorbic acid. After 8 
days of incubation significant keratinocyte differentiation was recorded along with an 
increase of many epidermal markers. Coraux et al. went on to grow these keratinocytes on 
stainless-steel grids that allowed then to grow in a 3-dimentional environment thus 
stimulating the differentiation of reconstituted skin. These finding could be used as a way of 
expanding this study. TERA2.SP12 EC cells could be exposed to BMP-4 or ascorbic acid 
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under similar culture conditions and it could be noted i f they would mimic this epidermal 
differentiation process. 
4.2 Anti-neural Genes and the B M P Signalling Pathway Which May 
Block Neurogenesis During TERA2.SP12 E C Cell Differentiation 
with H M B A 
The expression of anti-neural genes was investigated to deduce whether in HMBA cultures 
these genes could be suppressing the production of neural cell types. The anti-neural genes 
selected were transducin-like-enhancer of split 1 and 2 {tlel and tle2). Both genes are 
associated with the Notch signalling pathway that controls various cellular interactions 
involved in certain cell fate determinations (Liu et al 1996). Among the cell fates over which 
the pathway exerts some control are both epidermal and neural cell fates. Notch signalling 
appears to inhibit differentiation of stem cells until the correct morphogenetic signals are 
activated, tlel has been shown to be a negative regulator of postmitotic neuronal 
differentiation in the mammalian central nervous system once ectodermal patterning has 
taken place (Yao et al 2000). In this investigation tlel was seen to be expressed evenly 
throughout all samples tested suggesting that it is present in all cultures and it could 
therefore play some role in the suppression of neurogenesis and induction of epidermis. 
However further analysis will be required to confirm this, especially whether tlel is down-
regulated during the formation of neurospheres from human EC cells since >95% of these 
cultures form exclusively neural cells (Stewart et al 2003). As noted above, the tle2 gene is 
also associated with pathways controlling the differentiation of stem cells in neural or 
epidermal direction (Liu et al 1996) and has been shown to be expressed in epidermal 
progenitor cells. In the current study tle2 expression was seen to increase as incubation with 
99 
either of the inducing agents continued which correlated with the presence of non-neural cell 
types that expressed markers of epithelial cells. These findings indicate that the production 
of epidermal lineages both in retinoic acid and HMBA induced differentiated cultures is 
likely. Again confirmation that this gene exerts a regulatory role would require further 
experimentation. 
As cultures of TERA2.SP12 cells appear to be able to produce epithelial cells that express 
markers indicative of epidermal cell types and under different culture conditions appear to 
have an ability to produce neurons, it is proposed that differentiation by human 
TERA2.SP12 cells resembles development of the embryonic ectoderm. It is the ectoderm 
that gives rise to the formation of skin epidermis and the neural components of the CNS 
(reviewed in Weinstein and Hemmati-Brivanlou 1999 and in this investigation). The BMP 
signalling pathway appears to play a major role in the regulation of this ectodermal 
patterning during development (Wilson and Hemmati-Brivanlou 1995, Hawley et al 1995 
and Massague 1998). To test whether TERA2.SP12 EC cells and their differentiated 
derivatives expressed the specific proteins and genes found in the BMP signalling pathway, 
expression levels of various genes was examined. In this study it was shown that BMP4, 
BMP6, msxl, gata-1, and Smad 1,4,6, and 7 were all expressed in cultures of both retinoic 
acid and HMBA-induced differentiated cells, both grown as aggregates and in monolayer 
cultures. This indicates that the BMP signalling pathway could be present and functional 
within these EC cells during differentiation, and that through this signalling the production 
of either neuronal or epidermal cells may be controlled. Interestingly, all of the proteins and 
genes tested showed even expression levels across all of the samples studied except for 
gata-1. This gene showed higher expression levels in aggregate cultures exposed to retinoic 
acid and correlated with high levels of epithelial markers. This could be due to the fact that 
gata-1 is part of a transduction mechanism that induces epidermal differentiation by 
initiating the inhibition of the default neural differentiation pathway. 
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The occurrence of the BMP signalling pathway within other EC cell lines has been 
investigated. Caricasole et al 2000 carried out investigations in this area on the 
NTERA2.cl.Dl cell line. RT-PCR analysis from these EC cells showed high expression 
profiles of the co-SMAD, SMAD4, and BMP-specific SMAD transcripts within these cells, 
indicating that genes involved in the BMP signalling pathway were active. Given the data 
available on embryonic ectodermal patterning, Caricasole et al (2000) went on to 
hypothesise that the exposure of NTERA2.cl.Dl EC cells to BMPs would result in 
epidermal differentiation. The expression of a pan-keratin marker was studied, and they 
found it to be expressed at higher levels after the EC cells were exposed to BMPs, 
confirming that these non-neural cell types were indeed epidermal. Similar results have been 
obtained in this investigation, supporting our conclusion that TERA2.SP12 EC cells are 
capable of forming ectodermal derivatives as a possible consequence of BMP signalling. 
4.3 TERA2.SP12 Embryonal Carcinoma Cells Grown as Aggregates 
The growth of TERA2.SP12 EC cells as aggregates in the presence of retinoic acid has been 
shown to greatly enhance the cellular differentiation of neurons (Stewart et al 2003). A 
possible explanation for this increased neuronal differentiation could be that as a result of 
this method of cell culture a disruption to the BMP signalling pathway occurs, blocking its 
ability to inhibit the default neural pathway. This hypothesis is currently under investigation 
in our laboratory and preliminary experimentation is included here. 
Analysis of TERA2.SP12 aggregates grown in suspension in the presence of retinoic acid 
has been carried out. Aggregates formed in the presence of retinoic acid, termed 
neurospheres, are shown to contain >95% neurons following 14 days of incubation (Stewart 
et al 2003). Large neurospheres can be readily purified and form intricate neural networks 
when plated onto laminin coated surfaces. Live staining of developing suspended aggregates 
has established that whilst most aggregate formations highly express neuronal differentiation 
markers such as VINIS-56, some smaller, irregular looking aggregates remain negative, and 
express cell surface markers specific for undifferentiated stem cells, such as TRA-1-60 
(Horrocks unpub) (Figure 4.1). On-going investigations in our laboratory have identified 
these negative aggregates as being embryoid body-like structures. It is possible that these 
structures contributed toward the formation of non-neural epithelial cell types when plated 
onto coverslips. The further three weeks un-inhibited incubation of these cells on the 
coverslips may allow for the differentiation of large quantities of epithelial tissue from such 
embryoid body structures, although this would need to be verified. Studies carried out on F9 
EC cell aggregates determined that when the cells were introduced to low concentrations of 
retinoic acid, the cells aggregated and formed embryoid bodies with an outer layer that 
appeared to represent a model of epithelium formation (Grover et al 1983). In this 
investigation, the early epidermal marker cytokeratin-8 appears to be expressed at a higher 
level in the retinoic acid aggregate cultures as opposed to HMBA aggregate cultures, which 
contrasts with observations from monolayer cultures. As suggested, a possible explanation 
for this increased expression of cytokeratin-8 is that when these aggregates are grown on 
coverslips for an extended period of time the undifferentiated cells found in the embryoid 
body-like structures undergo differentiation on the glass plate, and start to undergo 
epidermal layer formation as seen in the F9 model (Grover et al 1983). This may possibly 
explain the increased expression of epithelial markers in our retinoic acid culture system 
under the conditions tested. I f this theory is correct then it may also explain the increased 
level of expression of the gene gata-1 as mentioned above, since gata-1 was also was 
expressed at a higher level in aggregates exposed to retinoic acid and can be used as an 
indication of epidermal differentiation. 
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FIGURE 4.1: Evidence of cell aggregates expressing stem cell markers in cultures 
exposed to retinoic acid. Corresponding phase (a,c) and fluorescent images (b,d) of cells 
cultured for 11 days in suspension. Large, spherical aggregates expressed VINIS-56 whilst 
significantly smaller irregular aggregates (arrow), were negative for this marker (a,b). 
Conversely, irregular aggregates expressed the stem cell marker TRA-1-60, whilst larger 
regular spheroids did not (arrows). Bars: (a,b 150ju m), (c,d 400/u m). Images courtesy of 
G Ho frocks. 
Results obtained from EC cells grown as aggregates and subsequently transferred to 
coverslips in the presence of either retinoic acid or HMBA also indicated that neural 
markers continued to be expressed at a high level in retinoic acid induced cultures but also 
appeared to be elevated slightly in HMBA samples compared with their monolayer culture 
counterparts. An explanation for this observation may involve cell-to-cell communication 
during differentiation and the disruption of the BMP signalling pathway. I f cell-to-cell 
contacts are disrupted then the neural default pathway may be activated due to the absence 
of extracellular inhibiting factors, such as BMPs, therefore resulting in the production of 
neural cells within the culture. This has been shown to be the case in disassociation studies 
examining Xenopus embryonic ectoderm cells. When the dissociation assays were carried 
out on the ectoderm, cells that under normal circumstances would form epidermis, took on a 
neuronal cell fate (Grunz and Tacke 1989). 
To summarise, the culture of aggregates in suspension greatly enhances neuronal 
differentiation (>95% Neurons) as previously described (Stewart et al 2003). However, Less 
than 5% of cells are therefore non-neuronal and have been shown to have an embryoid 
body-like structure. It is suggested here that this 5% of non-neuronal, undifferentiated cells 
must contribute to the further growth of epidermal cell types seen after the aggregates have 
been plated onto coverslips for a further three weeks. As there is a slight increase in 
neurogenesis in HMBA-induced cultures, it is also proposed that the lack of cell-to-cell 
contact consequential of this method of cell culture may potentiate any small amount of 
neural differentiation in the presence of HMBA 
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4.4 TERA2.SP12 Embryonal Carcinoma Stem Cells as a Model for 
Ectodermal Patterning in the Human Embryo 
The data presented in this investigation provide some preliminary evidence which suggests 
that the TERA2.SP12 EC stem cell line could be a useful model viable for research into 
ectodermal patterning during human embryonic development. EC cells have already been 
proven to be a useful model of human development due to their close relationship with germ 
cells within the embryo (See Figure 1.5) (Andrews et al 2001). Every EC cell line appears to 
have a different capacity for differentiation. TERA2.SP12 EC cells have been shown to have 
a greater capacity for neural and glial formation (Przyborski 2001), and as shown in this 
study, also appears to have the capacity to differentiate into epithelial tissues indicative of 
immature epidermis. 
Before the TERA2.SP12 EC cell line can be established as a model of human ectodermal 
patterning, further analysis wi l l have to be carried out. Further clarification of the epidermal 
nature of the differentiated non-neural cells may involve the use of epidermal markers other 
than keratin, such as pl-integrin, E-cadherin and plakoglobulin, which are all markers of 
epidermal progenitors cells (Watt 1998). Further investigation is also required to establish 
the role of BMPs in the differentiation of cells into neural or epidermal cell types within this 
particular cell line. This would help verify whether the BMP signalling pathway is 
conserved between EC cell differentiation and embryonic ectodermal development. 
I f such further analysis indicated that the TERA2.SP12 EC cell line was a viable model for 
ectodermal patterning in the human then this would become a very useful research tool in 
many areas of science. For instance, as a model for use in drug discovery programmes and 
toxicological testing, perhaps ultimately leading to the production of synthesized skin grafts, 
and neural transplantations to overcome tissue trauma and degenerative disease. 
Furthermore, a model of ectodermal development EC cells would also be useful as a tool for 
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understanding the molecular mechanisms underlying human ectodermal development. At 
present, there is little data available on human embryonic development due to the many 
ethical and moral issues surrounding the use of embryonic and foetal tissues required for this 
type of research. Since the TERA2.SP12 cell line originates from unwanted tumour tissue it 
would overcome these particular ethical and moral issues. 
For the areas of research outlined, human EC cells appear to form a more robust, readily 
available and more user-friendly cell line to work with than human ES cells. Although 
human ES cells are derived from the blastocysts and would ideally serve as a better model, 
they are still surrounded by strict guidelines for their use and there are practical and 
technical problems associated with their handling such as their dependence on feeder cells 
and their tendency to spontaneously differentiate (Andrews et al 2001). 
CONCLUSION 
The differentiation pathways of TERA2.SP12 EC stem cells are different when exposed to 
either retinoic acid or HMBA. The introduction of retinoic acid into the culture medium 
initiates the differentiation of neural and epithelial sub-types, whereas the introduction of 
HMBA initiates the almost exclusive differentiation of epithelial cells (Figure 4.2). The 
pathways appear to bear a relationship to the differentiation pathways seen during 
ectodermal patterning in the developing vertebrate embryo. I conclude therefore, that the 
human TERA2.SP12 EC stem cell system may be a viable and practical model for the use of 
research into this area of developmental biology. 
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FIGURE 4.2 Ectodermal patterning by human embryonal carcinoma cells. 
Schematic illustrating the primary directions of TERA2.SP12 cell differentiation 
studied during this investigation. 
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